cerebrovascular disorder: A disorder resulting from inadequate blood flow in the vessels that supply the brain. Representative examples include cerebrovascular ischemia, cerebral embolism, and cerebral infarction.
Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere
DOID EFO Endpoint Browser PheWeb
I9_CEREBDOTH
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
2724 |
4. Check minimum number of eventsNone |
2724 |
5. Include endpointsNone |
2724 |
6. Filter based on genotype QC (FinnGen only) |
2724 |
Control definitions (FinnGen only)
- Control exclude
- I9_CEREBVASC
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
Similar endpoints
↥List of similar endpoints to
Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere
based on the number of shared cases.
Similar with more cases:
- Cerebrovascular diseases
- Neurological diseases, wide definition
- Cardiovascular diseases
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 35100 | 17373 | 17089 |
| Only index persons | 20088 | 10110 | 9978 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.49 | 0.50 | 0.48 |
| Only index persons | 0.38 | 0.37 | 0.38 |
| Median age at first event (years) | |||
| Whole population | 72.53 | 75.26 | 69.77 |
| Only index persons | 69.92 | 72.84 | 66.95 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 2724 | 1196 | 1528 |
| Unadjusted period prevalence (%) | 0.56 | 0.41 | 0.67 |
| Median age at first event (years) | 67.39 | 66.28 | 68.25 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 2423
- Matched controls
- 24187
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
I63.3
ICD-10 Finland
Cerebral infarction due to thrombosis of cerebral arteries
4045.7
323.0
359
*
I67.9
ICD-10 Finland
Cerebrovascular disease, unspecified
2220.0
323.0
950
7
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
385.9
323.0
916
38
I67.8
ICD-10 Finland
Other specified cerebrovascular diseases
3725.6
323.0
335
*
B01AC30
ATC
platelet aggregation inhibitors excl. heparin - combinations
17.2
323.0
599
452
G46.3*I67.9
ICD-10 Finland
Brain stem stroke syndrome (I60-I67+)
+∞
323.0
393
*
G46.4*I67.9
ICD-10 Finland
Cerebellar stroke syndrome
6573.4
323.0
531
*
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
285.3
323.0
804
42
AA1AD
NOMESCO Finland
CT of head and brain
4.7
230.9
1009
3172
B01AC04
ATC
clopidogrel; oral
4.5
184.2
789
2327
4360A
ICD-9 Finland
Acute but ill-defined cerebrovascular disease[MORBUS CEREBROVASCULARIS ACUTUS NON DEFINITUS]
+∞
155.8
148
*
I63.4
ICD-10 Finland
Cerebral infarction due to embolism of cerebral arteries
+∞
153.7
146
*
K90
ICPC
Stroke/cerebrovascular accident
36.6
153.6
199
59
PA6BD
NOMESCO Finland
Extensive CT of neck arteries
12.7
145.7
271
238
G46.8*I67.9
ICD-10 Finland
Other vascular syndromes of brain in cerebrovascular diseases
1357.9
133.5
129
*
B01AC07
ATC
dipyridamole; systemic
6.2
129.0
380
708
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
5.7
127.8
406
830
R42
ICD-10 Finland
Dizziness and giddiness
3.3
126.6
822
3264
G46.7*I67.9
ICD-10 Finland
Other lacunar syndromes
+∞
114.4
109
*
I63.0
ICD-10 Finland
Cerebral infarction due to thrombosis of precerebral arteries
+∞
105.9
101
*
XA800
NOMESCO Finland
Neuropsychological investigation
11.5
95.7
185
173
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
5.6
95.7
303
606
G46.4
ICD-10 Finland
Cerebellar stroke syndrome
324.4
92.4
93
*
I67.1
ICD-10 Finland
Cerebral aneurysm, nonruptured
452.9
88.7
88
*
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.9
83.0
611
2519
4340A
ICD-9 Finland
Occlusion of cerebral arteries, Cerebral thrombosis
+∞
79.5
76
*
C10AA05
ATC
atorvastatin; oral
2.3
77.5
1099
6437
G45.0
ICD-10 Finland
Vertebro-basilar artery syndrome
8.7
75.7
170
208
I63.5
ICD-10 Finland
Cerebral infarction due to unspecified occlusion or stenosis of cerebral arteries
728.0
72.5
71
*
I63.8
ICD-10 Finland
Other cerebral infarction
187.7
70.4
73
*
AA5BD
NOMESCO Finland
CT of cerebral ischaemia
19.2
69.3
107
58
C10AA01
ATC
simvastatin; oral
2.1
65.8
1292
8527
I65.2
ICD-10 Finland
Occlusion and stenosis of carotid artery
82.3
64.3
72
9
43899
ICD-8 Finland
Other and ill-defined cerebrovascular disease, Without mention of hypertension
+∞
63.8
61
*
G46.3
ICD-10 Finland
Brain stem stroke syndrome
632.9
63.1
62
*
4380A
ICD-9 Finland
Late effects of cerebrovascular disease[SEQUELAE MORBI CEREBROVASCULARIS]
+∞
62.7
60
*
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
4.4
61.4
240
592
PA6DE
NOMESCO Finland
Neck artery ultrasound examination with Doppler method
5.4
60.2
191
377
I63.1
ICD-10 Finland
Cerebral infarction due to embolism of precerebral arteries
+∞
59.6
57
*
K91
ICPC
Cerebrovascular disease
28.8
59.5
81
29
B01AA03
ATC
warfarin; systemic
2.2
57.4
774
4271
R51.80
ICD-10 Finland
Headache
3.0
57.0
362
1319
R4120
NOMESCO Finland
Occupational therapy
4.9
56.9
197
428
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
3.2
55.7
332
1158
I61.9
ICD-10 Finland
Intracerebral haemorrhage, unspecified
148.2
55.0
58
*
I69.1
ICD-10 Finland
Sequelae of intracerebral haemorrhage
148.2
55.0
58
*
I63.2
ICD-10 Finland
Cerebral infarction due to unspecified occlusion or stenosis of precerebral arteries
276.4
53.3
54
*
I67.3
ICD-10 Finland
Progressive vascular leukoencephalopathy
31.2
52.6
70
23
315
Kela drug reimbursment
Clopidogrel
13.8
52.1
91
68
I10
ICD-10 Finland
Essential (primary) hypertension
1.9
50.9
1565
11742
I61.0
ICD-10 Finland
Intracerebral haemorrhage in hemisphere, subcortical
+∞
48.0
46
*
PAF14
NOMESCO Finland
Thrombendarterectomy of internal carotid artery
101.9
45.9
50
5
G45.1
ICD-10 Finland
Carotid artery syndrome (hemispheric)
5.2
45.2
146
293
R53
ICD-10 Finland
Malaise and fatigue
2.1
44.4
578
3077
AAL10
NOMESCO Finland
Intracranial endovascular thrombolysis
423.9
42.2
42
*
I69.0
ICD-10 Finland
Sequelae of subarachnoid haemorrhage
423.9
42.2
42
*
I60.9
ICD-10 Finland
Subarachnoid haemorrhage, unspecified
423.9
42.2
42
*
PA2CC
NOMESCO Finland
Cerebral very extensive angiography with X-ray
61.0
41.3
48
8
N18
ICPC
Paralysis/weakness
10.0
40.4
82
84
205
Kela drug reimbursment
Chronic hypertension
1.8
40.0
910
5955
C09AA05
ATC
ramipril; oral
1.9
39.6
734
4465
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
4.2
39.3
158
398
I63
ICD-10 Finland
Cerebral infarction
43.4
38.2
47
11
G46.5*I67.9
ICD-10 Finland
Pure motor lacunar syndrome
+∞
37.6
36
*
PA2BC
NOMESCO Finland
Cerebral extensive angiography with X-ray
83.3
36.9
41
5
I64
ICD-10 Finland
Stroke, not specified as haemorrhage or infarction
83.3
36.9
41
5
AAC00
NOMESCO Finland
Ligature of intracranial aneurysm
+∞
36.5
35
*
4378X
ICD-9 Finland
Other and ill-defined cerebrovascular disease, Other[MORBUS CERBROVASCULARIS ALIA DEFINITA]
+∞
36.5
35
*
C08CA01
ATC
amlodipine; oral
1.8
35.8
958
6543
XF400
NOMESCO Finland
ECG with 12 standard connections
2.1
35.6
488
2624
H53.4
ICD-10 Finland
Visual field defects
8.1
34.8
80
102
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.8
34.5
791
5127
G81.9
ICD-10 Finland
Hemiplegia, unspecified
15.4
33.9
56
37
PA2BD
NOMESCO Finland
Extensive CT angiography of brain
12.2
33.9
62
52
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
2.9
33.2
220
814
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.1
33.1
431
2258
TAB00
NOMESCO Finland
Lumbar puncture
4.5
33.0
122
283
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
2.8
32.8
226
857
I69.8
ICD-10 Finland
Sequelae of other and unspecified cerebrovascular diseases
118.1
32.7
35
*
PA7CD
NOMESCO Finland
CT angiography of neck and brain, extensive
16.1
30.3
49
31
I67.0
ICD-10 Finland
Dissection of cerebral arteries, nonruptured
+∞
30.2
29
*
G40.9
ICD-10 Finland
Epilepsy, unspecified
4.8
30.0
104
226
G46.8
ICD-10 Finland
Other vascular syndromes of brain in cerebrovascular diseases
68.7
29.9
34
5
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.7
29.1
211
824
E78.01
ICD-10 Finland
Pure hypercholesterolaemia
1.9
29.1
506
2957
G46.6*I67.9
ICD-10 Finland
Pure sensory lacunar syndrome
+∞
28.2
27
*
PA7AD
NOMESCO Finland
CT angiography of head and neck vasculature
5.9
27.5
78
135
G44.2
ICD-10 Finland
Tension-type headache
2.3
27.2
273
1268
R20.2
ICD-10 Finland
Paraesthesia of skin
3.2
26.2
144
469
N03AG01
ATC
valproic acid; systemic, rectal
3.2
25.9
142
462
R1260
NOMESCO Finland
Evaluation of communicative skills
6.8
25.5
65
98
F01.9
ICD-10 Finland
Vascular dementia, unspecified
5.1
25.4
82
166
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
7.2
24.9
61
87
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.6
24.8
1013
7546
WX892
NOMESCO Finland
Monitored bed care
2.5
24.6
204
858
AA5PD
NOMESCO Finland
CT examination of brain pefusion
24.5
24.3
34
14
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
6.3
24.1
65
106
C03CA01
ATC
furosemide; systemic
1.6
23.9
943
6941
N03AF02
ATC
oxcarbazepine; oral
4.4
23.3
85
196
PA7BD
NOMESCO Finland
CT angiography of neck and brain
6.9
23.2
58
85
A28
ICPC
Limited function/disability NOS
1.8
22.9
454
2745
AA1BM
NOMESCO Finland
MRI examination of brain with 3 Tesla magnet
9.3
22.3
46
50
R4150
NOMESCO Finland
Neuropsychological rehabilitation
27.5
22.2
30
11
N02BE01
ATC
paracetamol; systemic, rectal
1.6
22.0
1897
16663
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
2.7
22.0
157
605
E78.5
ICD-10 Finland
Hyperlipidaemia, unspecified
2.1
21.7
254
1260
R56.8
ICD-10 Finland
Other and unspecified convulsions
3.2
21.7
119
388
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.2
21.6
245
1199
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.8
21.6
385
2246
C01DA14
ATC
isosorbide mononitrate; oral
1.7
21.5
556
3638
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
2.1
21.5
270
1381
I25.1
ICD-10 Finland
Atherosclerotic heart disease
1.6
21.4
686
4756
N19
ICPC
Speech disorder
11.6
21.2
39
34
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
2.5
21.2
178
751
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.9
21.1
360
2065
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
2.0
21.0
300
1614
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
2.2
21.0
226
1080
A10AE04
ATC
insulin glargine; parenteral
2.1
20.6
242
1201
N06AB04
ATC
citalopram; systemic
1.7
20.6
466
2931
C10AA07
ATC
rosuvastatin; oral
1.7
20.6
527
3437
AAF00
NOMESCO Finland
Ventriculostomy
17.0
20.4
32
19
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.8
20.4
360
2085
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.9
20.4
356
2058
H53.2
ICD-10 Finland
Diplopia
3.6
19.8
91
259
43399
ICD-8 Finland
Cerebral thrombosis, Without mention of hypertension
+∞
19.8
19
*
R4130
NOMESCO Finland
Speech therapy
5.2
19.5
61
120
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
3.6
19.4
89
253
N06AB10
ATC
escitalopram; oral
1.8
19.3
337
1946
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.6
19.3
145
577
I95.1
ICD-10 Finland
Orthostatic hypotension
2.9
19.3
122
438
N03AX14
ATC
levetiracetam; systemic
4.7
19.2
65
140
I25.9
ICD-10 Finland
Chronic ischaemic heart disease, unspecified
1.8
19.1
361
2142
103
Kela drug reimbursment
Diabetes, insulin-treated
1.6
18.9
679
4822
C10AX09
ATC
ezetimibe; oral
2.0
18.6
246
1281
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.1
18.6
210
1025
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
1.6
18.5
687
4904
G46.7
ICD-10 Finland
Other lacunar syndromes
191.0
18.5
19
*
R41.3
ICD-10 Finland
Other amnesia
3.2
18.4
98
313
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
4.2
18.4
70
169
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.6
18.2
602
4178
I48
ICD-10 Finland
Atrial fibrillation and flutter
1.5
17.8
687
4941
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
5.6
17.6
51
92
R47.0
ICD-10 Finland
Dysphasia and aphasia
9.3
17.6
36
39
R1230
NOMESCO Finland
Neuropsychological evaluation of need and possibilities to rehabilitation
12.5
17.6
31
25
TPH04
NOMESCO Finland
Cathetrisation of vein
1.6
17.4
470
3091
R4110
NOMESCO Finland
Physiotherapy
1.6
17.4
561
3866
S06.0
ICD-10 Finland
Concussion
2.0
17.3
224
1157
PA6CG
NOMESCO Finland
Extensive MRI examination of neck vasculature with high intensity magnet
21.0
17.3
25
12
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
2.2
17.0
178
840
4019X
ICD-9 Finland
Essential hypertension, Unspecified
2.5
17.0
137
567
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.5
16.9
675
4884
R55
ICD-10 Finland
Syncope and collapse
1.8
16.8
290
1662
2161
FHL
Neck ligation, big brain
+∞
16.7
16
*
PAN14
NOMESCO Finland
Plastic repair of arteries internal carotid artery
90.5
16.6
18
*
E11.00
ICD-10 Finland
Non-insulin dependent diabetes diabetic hypoglycaemic coma
2.7
16.5
117
449
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
2.3
16.5
152
675
I67.2
ICD-10 Finland
Cerebral atherosclerosis
27.7
16.5
22
8
N03AF01
ATC
carbamazepine; oral, rectal
2.5
16.1
132
552
I69
ICD-10 Finland
Sequelae of cerebrovascular disease
30.2
16.1
21
7
R47.1
ICD-10 Finland
Dysarthria and anarthria
9.0
15.9
33
37
N06AX11
ATC
mirtazapine; oral
1.5
15.8
631
4553
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.6
15.8
431
2834
43800
ICD-8 Finland
Other and ill-defined cerebrovascular disease, With hypertension (benign)
+∞
15.6
15
*
PA2YT
NOMESCO Finland
Cerebral artery PTA with stent
+∞
15.6
15
*
SPAT1216
SPAT
Assessment of functional ability
1.7
15.4
392
2528
N03AX12
ATC
gabapentin; oral
1.7
15.4
317
1922
280
Kela drug reimbursment
Clopidogrel
3.9
15.3
62
160
P20
ICPC
Memory disturbance
1.7
15.2
355
2234
C07AB07
ATC
bisoprolol; oral
1.4
15.2
1170
9609
N05AH04
ATC
quetiapine; oral
1.8
15.2
297
1775
SPAT1229
SPAT
Assessment of need for aid
2.0
15.1
208
1101
Z01.8
ICD-10 Finland
Other specified special examinations
1.6
15.0
434
2896
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.7
14.9
331
2053
J01DA01
ATC
[U] cefalexin; systemic
1.4
14.9
1344
11349
A02BC02
ATC
pantoprazole; systemic
1.4
14.9
1377
11680
206
Kela drug reimbursment
Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease
1.5
14.9
581
4164
Q28.2
ICD-10 Finland
Arteriovenous malformation of cerebral vessels
31.8
14.8
19
6
R41.0
ICD-10 Finland
Disorientation, unspecified
2.7
14.8
99
369
C01DA02
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
1.5
14.7
680
5049
N02AX02
ATC
tramadol; systemic, rectal
1.4
14.7
930
7356
G40.20
ICD-10 Finland
Complex partial seizures with only alteration of consciousness
7.5
14.6
34
46
N03AB02
ATC
phenytoin; systemic
6.0
14.6
40
68
PA2VT
NOMESCO Finland
Intravascular evacuation of brain artery embolus
+∞
14.6
14
*
XCK00
NOMESCO Finland
Perimetry
2.1
14.5
170
843
PA2AC
NOMESCO Finland
Cerebral angiography with X-ray
150.5
14.5
15
*
G43.9
ICD-10 Finland
Migraine, unspecified
3.0
14.4
83
282
N06AA09
ATC
amitriptyline; systemic
1.9
14.1
225
1255
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.4
14.0
882
6947
SPAT1224
SPAT
Implementation of speech therapy rehabilitation plan
5.8
14.0
39
68
N05AX08
ATC
risperidone; systemic
1.9
13.9
204
1103
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.7
13.8
337
2145
PA6BG
NOMESCO Finland
MRI examination of neck vasculature with high intensity magnet
23.9
13.8
19
8
R11
ICD-10 Finland
Nausea and vomiting
2.0
13.7
177
914
PA7CC
NOMESCO Finland
Very extensive angiography of arteries of neck and brain
75.4
13.6
15
*
4371A
ICD-9 Finland
Other and ill-defined cerebrovascular disease, Other generalised ischaemic cerebrovascular disease
+∞
13.5
13
*
4300A
ICD-9 Finland
Subarachnoid haemorrhage[HAEMORRHAGIA SUBARACHNOID. POST ANEURYSMA SACCULARE]
+∞
13.5
13
*
I67.6
ICD-10 Finland
Nonpyogenic thrombosis of intracranial venous system
+∞
13.5
13
*
A10BA02
ATC
metformin; oral
1.5
13.5
654
4889
J69.0
ICD-10 Finland
Pneumonitis due to food and vomit
3.4
13.5
66
200
I50.9
ICD-10 Finland
Heart failure, unspecified
1.6
13.5
449
3091
R06.0
ICD-10 Finland
Dyspnoea
1.5
13.4
554
4007
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
1.5
13.4
533
3822
TPX22
NOMESCO Finland
Intravenous arterial thrombolysis
18.3
13.3
20
11
213
Kela drug reimbursment
Fat metabolism disorder associated with chronic coronary artery disease
1.8
13.3
239
1385
N28
ICPC
Limited function/disability (N)
4.3
13.2
48
113
G43.1
ICD-10 Finland
Migraine with aura [classical migraine]
2.6
13.1
93
359
M03BX01
ATC
baclofen; systemic
5.1
12.9
40
80
2500A
ICD-9 Finland
Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE,TYYPPI II]
2.3
12.7
116
514
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.6
12.6
385
2591
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.5
12.6
584
4317
I62.0
ICD-10 Finland
Nontraumatic subdural haemorrhage
70.1
12.6
14
*
I60.8
ICD-10 Finland
Other subarachnoid haemorrhage
+∞
12.5
12
*
I60.7
ICD-10 Finland
Subarachnoid haemorrhage from intracranial artery, unspecified
+∞
12.5
12
*
4349A
ICD-9 Finland
Occlusion of cerebral arteries, Cerebral artery occlusion, unspecified[OCCL/STENOS ARTER.CEREBRALES NUD CUM INFARCTU CEREB]
+∞
12.5
12
*
I61.1
ICD-10 Finland
Intracerebral haemorrhage in hemisphere, cortical
+∞
12.5
12
*
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
4.2
12.5
46
110
J01MA02
ATC
ciprofloxacin; systemic
1.4
12.4
887
7106
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
1.8
12.3
224
1307
S06.5
ICD-10 Finland
Traumatic subdural haemorrhage
2.6
12.3
88
341
N03AX16
ATC
pregabalin; oral
1.5
12.3
460
3252
C07AB02
ATC
metoprolol; systemic
1.5
12.3
564
4161
C08CA05
ATC
nifedipine; systemic
1.9
12.2
189
1044
PA6AE
NOMESCO Finland
Ulrasound examination of neck vasculature
5.5
12.2
35
64
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
2.0
12.1
156
805
PA6AD
NOMESCO Finland
CT of neck arteries
7.0
12.1
29
42
PA2BG
NOMESCO Finland
MRI examination of vessels in the head with high intensity magnet
18.1
12.0
18
10
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
1.8
12.0
217
1261
R07.4
ICD-10 Finland
Chest pain, unspecified
1.4
12.0
579
4310
I50.0
ICD-10 Finland
Congestive heart failure
1.7
11.9
250
1525
C09CA01
ATC
losartan; oral
1.5
11.8
528
3865
AN1
HP
Coronary angiography
1.6
11.5
305
1981
I25.2
ICD-10 Finland
Old myocardial infarction
1.7
11.5
222
1318
G45
ICD-10 Finland
Transient cerebral ischaemic attacks and related syndromes
6.5
11.5
29
45
H53.1
ICD-10 Finland
Subjective visual disturbances
2.2
11.5
115
532
I60.0
ICD-10 Finland
Subarachnoid haemorrhage from carotid siphon and bifurcation
+∞
11.5
11
*
I65.3
ICD-10 Finland
Occlusion and stenosis of multiple and bilateral precerebral arteries
+∞
11.5
11
*
AAL00
NOMESCO Finland
Endovascular occlusion of intracranial aneurysm
+∞
11.5
11
*
K89
ICPC
Transient cerebral ischaemia
5.7
11.4
32
57
J01EA01
ATC
trimethoprim; systemic
1.4
11.4
557
4148
N05CF01
ATC
zopiclone; oral
1.4
11.4
757
5968
E11.5
ICD-10 Finland
Type 2 diabetes mellitus, with peripheral circulatory complications
2.8
11.3
70
250
N30.0
ICD-10 Finland
Acute cystitis
1.6
11.1
284
1827
J01DB01
ATC
cefalexin; oral
1.4
11.1
1651
14778
R51
ICD-10 Finland
Headache
2.5
11.0
84
339
AA1AG
NOMESCO Finland
Short MRI examination of brain with median intensity magnet
6.1
11.0
29
48
SPAT1053
SPAT
Memory test
1.5
11.0
418
2955
N03AX09
ATC
lamotrigine; oral
2.9
10.9
65
228
I20.81
ICD-10 Finland
Other angina pectoris stenosed coronary artery
1.7
10.9
231
1409
SPAT1254
SPAT
Administration of medicine
1.6
10.9
339
2291
A10AA02
ATC
NA
2.3
10.8
96
422
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
2.4
10.8
89
375
I70.9
ICD-10 Finland
Generalized and unspecified atherosclerosis
2.9
10.8
65
230
M79.6
ICD-10 Finland
Pain in limb
1.4
10.8
667
5182
A10BB12
ATC
glimepiride; oral
1.7
10.7
209
1245
TKC20
NOMESCO Finland
Catheterisation of bladder
1.8
10.7
183
1047
X59
ICD-10 Finland
Exposure to unspecified factor
1.5
10.6
338
2297
C09AA02
ATC
enalapril; systemic
1.4
10.5
509
3775
43300
ICD-8 Finland
Cerebral thrombosis, Wtih hypertension (benign)
+∞
10.4
10
*
I65.0
ICD-10 Finland
Occlusion and stenosis of vertebral artery
+∞
10.4
10
*
PA2LT
NOMESCO Finland
Endovascular closure of extensive brain aneurysm
+∞
10.4
10
*
N17
ICPC
Vertigo/dizziness
1.7
10.3
234
1457
C10AA03
ATC
pravastatin; oral
1.8
10.3
181
1043
J01FF01
ATC
clindamycin; systemic
1.4
10.2
509
3799
H81.4
ICD-10 Finland
Vertigo of central origin
5.0
10.1
31
62
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.7
10.1
211
1284
N05BA04
ATC
oxazepam; oral
1.4
10.1
507
3785
PA2AD
NOMESCO Finland
CT angiography of brain
14.6
10.0
16
11
C03AA03
ATC
hydrochlorothiazide; oral
1.6
9.8
238
1511
J01CA08
ATC
pivmecillinam; oral
1.4
9.8
715
5695
N06AB03
ATC
fluoxetine; oral
1.7
9.8
222
1384
81
HP
Angiography of the heart and coronary arteries
1.7
9.7
199
1204
XCK10
NOMESCO Finland
Photography of fundus of eye
1.6
9.7
231
1458
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
2.2
9.7
91
413
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.4
9.6
625
4883
C10AA04
ATC
fluvastatin; oral
1.6
9.5
224
1407
N06AX21
ATC
duloxetine; oral
1.8
9.5
174
1016
Q28.3
ICD-10 Finland
Other malformations of cerebral vessels
17.6
9.4
14
8
4373A
ICD-9 Finland
Other and ill-defined cerebrovascular disease, Cerebral aneurysm, nonruptured
+∞
9.4
9
*
I61.3
ICD-10 Finland
Intracerebral haemorrhage in brain stem
+∞
9.4
9
*
I65.1
ICD-10 Finland
Occlusion and stenosis of basilar artery
+∞
9.4
9
*
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.5
9.3
339
2371
XF620
NOMESCO Finland
Examination of circulation with color method
10.7
9.3
17
16
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
2.1
9.3
105
518
G51.0
ICD-10 Finland
Bell palsy
2.9
9.2
53
182
M48.0
ICD-10 Finland
Spinal stenosis
1.5
9.1
283
1908
I20.01
ICD-10 Finland
Unstable angina
2.2
9.1
87
399
F01.19
ICD-10 Finland
Multi-infarct dementia without information on additional symptoms
11.5
9.0
16
14
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.6
9.0
214
1349
E78.9
ICD-10 Finland
Disorder of lipoprotein metabolism, unspecified
2.2
8.9
88
409
JDB10
NOMESCO Finland
Percutaneous gastrostomy
3.8
8.9
36
96
XCW99
NOMESCO Finland
Other investigative procedure of eye
1.6
8.9
242
1580
A06AD11
ATC
lactulose; oral
1.4
8.8
403
2949
G91.1
ICD-10 Finland
Obstructive hydrocephalus
8.0
8.8
19
24
P29
ICPC
Psychological sympt/compl other
2.4
8.7
71
301
A12BA01
ATC
potassium chloride; oral
1.8
8.7
160
936
SPAT1301
SPAT
No procedures
1.3
8.6
667
5342
40199
ICD-8 Finland
Essential benign hypertension
2.3
8.6
73
316
25000
ICD-8 Finland
Diabetes mellitus, Sine complicatione
2.3
8.6
73
316
H81.1
ICD-10 Finland
Benign paroxysmal vertigo
1.7
8.6
183
1120
R90.8
ICD-10 Finland
Other abnormal findings on diagnostic imaging of central nervous system
5.8
8.6
23
40
I20.09
ICD-10 Finland
Unstable angina
1.8
8.5
150
866
C08CA02
ATC
felodipine; oral
1.6
8.5
240
1581
F01.10
ICD-10 Finland
Multi-infarct dementia without additional symptoms
9.0
8.5
17
19
R13
ICD-10 Finland
Dysphagia
1.8
8.5
137
769
79199
ICD-8 Finland
Headache
3.1
8.5
44
143
5541
FHL
Subclavia and / or carotid endarterectomy, reconstruction or bypass surgery
27.5
8.5
11
*
R47.8
ICD-10 Finland
Other and unspecified speech disturbances
5.1
8.4
25
49
215
Kela drug reimbursment
Diabetes, non-insulin-treated
1.4
8.4
479
3644
A02BC03
ATC
lansoprazole; oral
1.3
8.4
624
4958
F01.30
ICD-10 Finland
Mixed cortical and subcortical vascular dementia without additional symptoms
7.3
8.4
19
26
SPAT1231
SPAT
Assessment of adjustments needed in living environment
2.7
8.4
57
217
N01
ICPC
Headache
1.8
8.4
134
751
XXA00
NOMESCO Finland
Clinical examination requiring general anaesthesia
7.9
8.3
18
23
43099
ICD-8 Finland
Subarachnoid haemorrhage, Without mention of hypertension
+∞
8.3
8
*
I67.5
ICD-10 Finland
Moyamoya disease
+∞
8.3
8
*
A10AB01
ATC
insulin (human); parenteral (insulins and analog. for injection, fast-acting)
2.3
8.3
73
321
B01AB05
ATC
enoxaparin; parenteral
1.3
8.3
622
4951
C08CA13
ATC
lercanidipine; oral
1.5
8.3
282
1941
C02AC05
ATC
moxonidine; oral
2.0
8.2
99
499
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
2.1
8.2
92
453
Z50.5
ICD-10 Finland
Speech therapy
4.5
8.1
27
60
4351A
ICD-9 Finland
Transient cerebral ischaemia, Vertebral artery syndrome
7.5
8.1
18
24
N06AX16
ATC
venlafaxine; oral
1.6
8.1
185
1155
XF404
NOMESCO Finland
Ambulatory ECG
1.6
8.1
193
1219
A10AE05
ATC
insulin detemir; parenteral
2.0
8.1
106
552
E11.3
ICD-10 Finland
Type 2 diabetes mellitus, with ophthalmic complications
2.4
8.1
66
281
7890A
ICD-9 Finland
Other symptoms involving abdomen and pelvis, Abdominal pain
2.0
8.0
102
527
M01AE03
ATC
ketoprofen; systemic, rectal
1.3
8.0
800
6634
Z02.7
ICD-10 Finland
Issue of medical certificate
1.9
8.0
121
666
E78.00
ICD-10 Finland
Familial hypercholesterolaemia
2.0
7.9
97
495
H81.2
ICD-10 Finland
Vestibular neuronitis
3.0
7.9
45
154
N29
ICPC
Neurological sympt/complt other
3.0
7.9
42
140
A49.9
ICD-10 Finland
Bacterial infection, unspecified
1.5
7.9
256
1745
F05.9
ICD-10 Finland
Delirium, unspecified
2.6
7.9
54
208
4350A
ICD-9 Finland
Transient cerebral ischaemia, Basilar artery syndrome
7.8
7.9
17
22
F03
ICD-10 Finland
Unspecified dementia
1.7
7.8
149
886
G90.2
ICD-10 Finland
Horner syndrome
9.4
7.8
15
16
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.3
7.7
591
4715
L28
ICPC
Limited function/disability (L)
1.4
7.6
353
2586
XFP96
NOMESCO Finland
Other intraoperative electrophysiological investigation in arhythmia or disturbance of impulse propagation
2.5
7.6
56
225
PA4AC
NOMESCO Finland
Vertebralis angiography with X-ray
25.0
7.6
10
*
R26.8
ICD-10 Finland
Other and unspecified abnormalities of gait and mobility
2.6
7.5
50
191
C03EA01
ATC
hydrochlorothiazide and potassium-sparing agents; oral
1.4
7.5
402
3022
F80.1
ICD-10 Finland
Expressive language disorder
6.2
7.5
19
31
SPAT1101
SPAT
Orthostatic test
1.8
7.5
121
679
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.5
7.5
266
1846
A10BH01
ATC
sitagliptin; oral
1.6
7.4
206
1353
F33.11
ICD-10 Finland
Recurrent depression, moderate episode of somatic syndrome
3.5
7.4
32
91
I25.0
ICD-10 Finland
Atherosclerotic cardiovascular disease, so described
1.6
7.4
172
1080
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
1.7
7.4
165
1021
I61.8
ICD-10 Finland
Other intracerebral haemorrhage
80.2
7.4
8
*
PA6CM
NOMESCO Finland
Extensive MRI examination of neck vasculature with 3 Tesla magnet
80.2
7.4
8
*
I69.2
ICD-10 Finland
Sequelae of other nontraumatic intracranial haemorrhage
80.2
7.4
8
*
ZXA00
NOMESCO Finland
Right side
1.3
7.3
583
4668
UKC02
NOMESCO Finland
Cystoscopy
1.4
7.3
389
2922
C03DA01
ATC
spironolactone; oral
1.5
7.3
261
1813
FN1AT
NOMESCO Finland
Endovascular dilatation of coronary arteries (PTCA)
1.8
7.3
132
770
4331X
ICD-9 Finland
Occlusion and stenosis of precerebral arteries, Carotid artery[OCCL/STENOSIS ARTERIAE CAROTIS SINE INFARCTU CEREBR]
+∞
7.3
7
*
I61.4
ICD-10 Finland
Intracerebral haemorrhage in cerebellum
+∞
7.3
7
*
I69.4
ICD-10 Finland
Sequelae of stroke, not specified as haemorrhage or infarction
+∞
7.3
7
*
4331A
ICD-9 Finland
Occlusion and stenosis of precerebral arteries, Carotid artery[OCCL/STENOSIS ARTERIAE CAROTIS CUM INFARCTU CEREBRI]
+∞
7.3
7
*
I67.4
ICD-10 Finland
Hypertensive encephalopathy
+∞
7.3
7
*
4341A
ICD-9 Finland
Occlusion of cerebral arteries, Cerebral embolism
+∞
7.3
7
*
PA2KT
NOMESCO Finland
Endovascular closure of brain aneurysm
+∞
7.3
7
*
S22.3
ICD-10 Finland
Fracture of rib
1.7
7.3
137
811
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.4
7.3
402
3041
AAF05
NOMESCO Finland
Ventriculoperitoneal shunt
3.5
7.3
32
93
M54.5
ICD-10 Finland
Low back pain
1.3
7.2
548
4357
S82.6
ICD-10 Finland
Fracture of lateral malleolus
1.9
7.2
105
570
E10.7
ICD-10 Finland
Type 1 diabetes mellitus, With multiple complications
2.8
7.2
44
161
G43.0
ICD-10 Finland
Migraine without aura [common migraine]
2.4
7.1
55
229
C09CA06
ATC
candesartan; oral
1.4
7.1
383
2881
J01FA06
ATC
roxithromycin; oral
1.3
7.1
776
6494
A10BB01
ATC
glibenclamide; oral
1.7
7.1
155
956
4130X
ICD-9 Finland
Angina pectoris, Angina decubitus[ANGINA PECTORIS (""""EFFORT ANGINA""""),MÄÄRITTELEMÄT]
2.1
7.0
75
363
G45.8
ICD-10 Finland
Other transient cerebral ischaemic attacks and related syndromes
5.6
7.0
19
34
I20.99
ICD-10 Finland
Angina pectoris, unspecified
1.6
7.0
180
1163
C02DE04
ATC
NA
1.9
7.0
98
528
N05CD07
ATC
temazepam; oral
1.4
7.0
327
2399
N30
ICD-10 Finland
Cystitis
1.7
7.0
124
724
SPAT1292
SPAT
Other function in accordance with SHToL (Finnish classification of nursing interventions)
1.6
6.9
193
1270
R04.0
ICD-10 Finland
Epistaxis
1.6
6.9
168
1065
V700A
ICD-9 Finland
General medical examination, Routine general medical examination at a health care facility
2.3
6.9
61
270
N05BA01
ATC
diazepam; systemic, rectal
1.5
6.9
263
1853
G40.12
ICD-10 Finland
Simple partial seizures with secondary generalization
5.8
6.9
18
31
PF1AT
NOMESCO Finland
Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)
3.4
6.9
31
92
F31.4
ICD-10 Finland
Bipolar affective disorder, current episode severe depression without psychotic symptoms
4.2
6.9
24
57
F01.2
ICD-10 Finland
Subcortical vascular dementia
4.8
6.8
21
44
N88
ICPC
Epilepsy
8.3
6.8
14
17
PA6AG
NOMESCO Finland
Limited MRI examination of neck vasculature with high intensity magnet
6.7
6.8
16
24
AAD10
NOMESCO Finland
Evacuation of chronic subdural haematoma
3.2
6.8
33
104
FN1BC
NOMESCO Finland
Extensive angiography of hear and/or coronary arteries
1.7
6.8
127
750
XX3XW
NOMESCO Finland
NA
6.1
6.8
17
28
C08CA06
ATC
nimodipine; systemic
40.1
6.7
8
*
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
2.1
6.7
75
370
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.4
6.7
300
2184
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
2.0
6.7
81
411
C09AA04
ATC
perindopril; oral
1.7
6.7
120
702
A46
ICD-10 Finland
Erysipelas
1.4
6.7
298
2166
N02AJ06
ATC
codeine and paracetamol; systemic
1.3
6.7
603
4914
4359X
ICD-9 Finland
Transient cerebral ischaemia, Unspecified transient cerebral ischaemia
4.9
6.6
20
41
G91.9
ICD-10 Finland
Hydrocephalus, unspecified
6.4
6.6
16
25
N06CA01
ATC
amitriptyline and psycholeptics; systemic
1.5
6.6
191
1270
183
Kela drug reimbursment
Lamotrigin and topiramate
5.9
6.6
17
29
J01DA09
ATC
[U] cefadroxil; inhalant, oral
1.3
6.6
498
3952
I72.0
ICD-10 Finland
Aneurysm and dissection of carotid artery
8.7
6.5
13
15
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.4
6.5
344
2576
F01.3
ICD-10 Finland
Mixed cortical and subcortical vascular dementia
10.0
6.5
12
12
H25.1
ICD-10 Finland
Senile nuclear cataract
1.3
6.5
689
5727
AA1BD
NOMESCO Finland
Extensive CT of head and brain
2.3
6.4
53
229
H51.2
ICD-10 Finland
Internuclear ophthalmoplegia
69.9
6.4
7
*
TPH07
NOMESCO Finland
Cathetrisation of artery
1.5
6.4
206
1401
7231A
ICD-9 Finland
Other disorders of cervical region, Cervicalgia
3.2
6.4
31
98
Z00.0
ICD-10 Finland
General medical examination
1.4
6.4
337
2524
7840A
ICD-9 Finland
Symptoms involving head and neck, Headache
3.4
6.4
28
82
PA2CG
NOMESCO Finland
Extensive MRI examination of vessels in the head with high intensity magnet
14.3
6.4
10
7
C09DA01
ATC
losartan and diuretics; oral
1.5
6.4
213
1464
C07AG02
ATC
carvedilol; oral
1.6
6.3
143
891
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
2.0
6.3
72
359
NA1CG
NOMESCO Finland
Cervical spine extensive MRI examination with high intensity magnet
3.0
6.3
33
110
N30.9
ICD-10 Finland
Cystitis, unspecified
1.7
6.3
116
684
I21.49
ICD-10 Finland
Acute subendocardial infarction unspecified coronary artery status
1.6
6.3
149
942
F01.29
ICD-10 Finland
Subcortical vascular dementia without information on additional symptoms
5.9
6.3
16
27
K59.1
ICD-10 Finland
Functional diarrhoea
1.8
6.3
98
549
E11.6
ICD-10 Finland
Type 2 diabetes mellitus, with other specified complications
2.5
6.3
46
188
H02AB06
ATC
prednisolone; systemic
1.2
6.3
945
8190
I62.9
ICD-10 Finland
Intracranial haemorrhage (nontraumatic), unspecified
+∞
6.2
6
*
I60.1
ICD-10 Finland
Subarachnoid haemorrhage from middle cerebral artery
+∞
6.2
6
*
I67.7
ICD-10 Finland
Cerebral arteritis, not elsewhere classified
+∞
6.2
6
*
G46.5
ICD-10 Finland
Pure motor lacunar syndrome
+∞
6.2
6
*
I60.3
ICD-10 Finland
Subarachnoid haemorrhage from posterior communicating artery
+∞
6.2
6
*
PA2MT
NOMESCO Finland
Endovascular closure of very extensive brain aneurysm
+∞
6.2
6
*
UJF32
NOMESCO Finland
Coloscopy
1.3
6.2
524
4219
PEF23
NOMESCO Finland
Thrombendarterectomy of femoral artery
2.5
6.2
45
183
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
1.6
6.2
162
1052
M04AA01
ATC
allopurinol; systemic
1.4
6.1
322
2410
N03AE01
ATC
clonazepam; systemic
1.8
6.1
102
582
SPAT1050
SPAT
Extensive neurological examination
2.4
6.1
50
214
G47.3
ICD-10 Finland
Sleep apnoea
1.4
6.1
337
2541
R26.2
ICD-10 Finland
Difficulty in walking, not elsewhere classified
3.2
6.1
29
91
F01.20
ICD-10 Finland
Subcortical vascular dementia without additional symptoms
4.0
6.1
22
55
C10AA02
ATC
lovastatin; oral
1.7
6.1
114
677
AA1AM
NOMESCO Finland
Short MRI examination of brain with 3 Tesla magnet
12.5
6.1
10
8
F31.9
ICD-10 Finland
Bipolar affective disorder, unspecified
2.8
6.1
36
130
Z95.1
ICD-10 Finland
Presence of aortocoronary bypass graft
1.7
6.0
110
645
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
1.6
6.0
151
967
G40.2
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
4.9
6.0
18
37
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3018677) aPTT in Platelet poor plasma by Coagulation assay
776
2806
3.46
169.39
2.1
1.9
s
29.4
30.0
2.19
749
2688
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
1189
5949
2.77
141.36
2.7
2.0
u/l
180.3
247.8
1.91
1123
5484
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
154
325
4.95
68.50
1.4
1.4
e6/l
1412.3
883.5
0.30
116
267
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
154
325
4.95
68.50
1.4
1.3
e6/l
43.3
36.5
0.06
114
257
(3036489) Thrombin time
190
508
3.94
62.31
1.9
2.0
s
20.5
21.8
2.88
162
446
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
160
384
4.35
60.67
1.5
1.3
mg/l
514.8
568.9
0.82
152
358
(3044290) Cell count panel - Cerebral spinal fluid
134
284
4.90
59.25
1.4
1.3
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
148
343
4.49
58.66
1.3
1.3
mmol/l
3.7
3.8
0.32
139
315
(3023410) Appearance of Cerebral spinal fluid
90
138
6.70
56.05
1.5
1.4
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
448
2098
2.35
53.61
2.7
2.4
ug/l
5.3
6.8
1.06
386
1785
(3033658) Prothrombin time (PT) actual/Normal
815
4820
1.98
53.31
4.3
3.8
%
84.1
85.1
0.50
791
4685
(3016018) Differential panel - Cerebral spinal fluid
83
136
6.25
48.46
1.4
1.3
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
492
2499
2.18
48.01
6.4
6.7
kpa
5.0
5.1
0.85
463
2362
(3027801) Oxygen [Partial pressure] in Arterial blood
491
2498
2.17
47.68
6.4
6.7
kpa
11.9
11.8
0.08
462
2362
(3003396) Base excess in Arterial blood by calculation
485
2504
2.13
45.15
6.5
6.7
mmol/l
1.4
1.2
0.39
363
1913
(3013826) Glucose [Moles/volume] in Serum or Plasma
1584
12103
1.73
41.31
5.8
4.6
mmol/l
6.9
6.9
0.26
1505
11329
(3022217) INR in Platelet poor plasma by Coagulation assay
564
3202
1.96
39.94
34.7
28.8
inr
1.6
1.5
0.65
47
448
(3032080) INR in Blood by Coagulation assay
1239
9006
1.68
37.50
13.4
10.8
inr
1.4
1.3
1.20
292
2429
(3016502) Oxygen saturation in Arterial blood
426
2254
2.05
36.56
6.7
7.0
%
95.0
95.2
0.19
409
2160
(3014576) Chloride [Moles/volume] in Serum or Plasma
488
2712
1.97
36.46
6.1
6.3
mmol/l
104.7
104.2
1.50
482
2637
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
82
175
4.79
35.93
1.4
1.2
u/ml
1.7
2.9
0.55
21
57
(3000991) Gas panel - Venous blood
356
1771
2.16
35.92
6.7
7.4
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
471
2618
1.96
35.05
1.9
1.8
—
—
—
0
0
(4306422)
78
163
4.89
35.04
1.1
1.2
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
78
164
4.86
34.79
1.3
1.2
u/ml
6.5
4.3
0.48
31
72
(3011397) Hemoglobin [Presence] in Urine by Test strip
723
4610
1.77
34.72
5.0
3.8
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
389
2037
2.06
34.20
7.1
7.5
g/l
119.1
119.7
0.18
374
1956
(3019309) Folate [Moles/volume] in Red Blood Cells
731
4736
1.74
32.91
1.8
1.8
nmol/l
1191.6
1171.6
0.24
568
3479
(3008152) Bicarbonate [Moles/volume] in Arterial blood
295
1412
2.22
32.66
7.5
6.4
mmol/l
24.6
24.5
0.09
280
1305
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
463
2620
1.92
32.47
2.0
1.7
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
1243
9280
1.62
32.18
5.0
4.5
g/l
34.5
34.7
0.71
1144
8511
(3026008) Bacteria identified in Urine by Culture
965
6839
1.63
30.41
4.0
3.4
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
1280
9729
1.59
30.02
6.6
5.8
mmol/l
1.2
1.2
6.48
1188
8676
(3023368) Bacteria identified in Blood by Culture
910
6389
1.63
29.60
4.6
4.3
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
354
1889
2.00
29.28
5.6
6.3
mmol/l
1.4
1.4
0.10
341
1812
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
652
4219
1.71
28.92
4.8
4.0
ng/l
240.5
702.0
1.37
550
3591
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
1382
10787
1.57
28.23
7.5
6.6
mmol/l
1.2
1.2
4.74
1217
8994
(4268621)
58
115
5.12
27.71
2.7
2.2
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
70
163
4.37
27.58
1.1
1.1
—
—
—
0
0
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
69
161
4.36
27.12
1.1
1.1
%
122.3
115.0
1.07
69
141
(3019150) Specific gravity of Urine by Refractometry
660
4380
1.66
26.26
5.8
4.3
kg/l
1.1
1.0
0.50
90
667
(3019060) Gas panel - Arterial blood
291
1508
2.04
26.00
5.0
4.5
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
323
1741
1.97
25.81
3.2
2.9
kpa
4.7
4.4
0.93
307
1675
(3021447) Carbon dioxide [Partial pressure] in Venous blood
373
2111
1.88
25.74
3.8
3.4
kpa
5.9
5.8
1.12
357
2034
(3020891) Body temperature
199
894
2.32
25.50
5.2
4.0
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
370
2102
1.88
25.21
4.0
3.4
mmol/l
2.0
2.0
0.04
303
1652
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
1114
8439
1.54
25.00
5.2
4.0
ng/l
42.9
88.8
1.26
861
6369
(3009466) Valproate [Moles/volume] in Serum or Plasma
77
211
3.72
24.35
4.1
4.5
umol/l
348.4
343.9
0.10
72
184
(3018418) pH of Serum or Plasma
882
6378
1.56
24.24
4.3
3.9
ph
7.4
7.4
0.79
110
1206
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
580
3792
1.67
24.19
2.1
1.9
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
1195
9244
1.52
24.01
2.3
2.1
pmol/l
92.4
93.2
0.24
661
4761
(3031040) Bacteria [#/volume] in Urine by Automated count
1650
13697
1.51
23.32
6.2
4.8
e6/l
326.6
2564.8
2.46
24
241
(4027681)
43
76
5.72
23.28
1.3
1.1
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
155
661
2.42
22.33
4.8
3.6
mmol/l
3.8
3.9
0.97
150
603
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
287
1572
1.92
21.73
1.8
1.6
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
24
23
10.49
21.73
1.3
1.0
—
—
—
0
0
(3014007) Fractional oxyhemoglobin in Arterial blood
253
1328
1.99
21.70
7.7
8.4
%
93.5
93.8
0.25
253
1318
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
49
106
4.68
21.19
1.3
1.1
mg/l
36.3
41.1
0.44
44
90
(36304419) Bacteria [Presence] in Urine
790
5721
1.53
20.94
3.6
3.2
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
45
92
4.95
20.80
1.2
1.0
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
611
4190
1.59
20.59
3.3
3.0
mmol/l
2.5
2.5
0.53
528
3655
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
541
3613
1.62
20.34
3.1
2.8
e6/l
2.1
1.2
1.07
311
2111
(3015736) pH of Urine
994
7604
1.48
20.00
4.7
3.6
—
5.8
—
0
9
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
50
117
4.32
19.63
1.2
1.1
%
95.9
96.3
0.04
50
110
(40761535) Cells panel - Urine sediment
319
1868
1.80
19.47
4.5
3.6
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
807
5945
1.50
19.45
3.7
3.2
e6/l
0.5
0.5
0.34
629
4573
(3003458) Phosphate [Moles/volume] in Serum or Plasma
433
2778
1.66
18.99
5.7
5.3
mmol/l
1.0
1.0
0.16
401
2540
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
41
84
4.93
18.92
1.2
1.1
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
207
1069
2.01
18.55
3.1
2.3
%
1.2
1.1
0.51
207
1060
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
53
137
3.92
18.26
1.5
1.3
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
497
3344
1.59
17.88
3.0
2.9
mmol/l
0.8
0.8
0.43
460
3066
(3007853) Bacteria identified in Skin by Aerobe culture
377
2368
1.68
17.86
1.9
1.8
—
—
—
0
0
(3003338) MCHC [Mass/volume]
1776
15379
1.44
17.28
31.2
21.3
g/l
330.7
331.5
2.81
1751
15199
(3002582) Erythrocytes [#/volume] in Urine
861
6552
1.46
17.17
3.8
3.3
e6/l
66.9
83.2
0.50
671
5125
(3035350) Ketones [Presence] in Urine by Test strip
1201
9727
1.42
16.93
5.0
3.8
estimate
0.0
0.0
0.00
173
1806
(3018095) Leukocytes [#/volume] in Urine
961
7484
1.43
16.86
4.5
3.7
e6/l
152.5
130.5
0.14
702
5472
(3006315) Basophils [#/volume] in Blood
1191
9647
1.41
16.71
5.8
5.4
e9/l
0.0
0.0
0.61
1014
8187
(3027273) Bicarbonate [Moles/volume] in Venous blood
217
1186
1.90
16.46
3.3
3.2
mmol/l
25.4
25.2
0.53
212
1141
(3001604) Monocytes [#/volume] in Blood
1183
9592
1.41
16.39
5.8
5.4
e9/l
0.6
0.6
1.44
1005
8127
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
771
5798
1.46
16.18
2.6
2.2
mg/l
3.1
3.1
0.10
657
4845
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
49
131
3.78
16.13
1.0
1.0
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
209
1146
1.89
15.69
8.8
9.6
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
414
2750
1.59
15.56
12.1
7.8
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
95
384
2.52
15.41
1.9
2.7
umol/l
28.0
34.9
2.76
79
311
(3009261) Glucose [Presence] in Urine by Test strip
1204
9870
1.39
15.27
5.0
3.9
estimate
0.0
0.0
0.80
177
1763
(3020779) Urea [Moles/volume] in Serum or Plasma
314
1967
1.67
14.91
6.3
6.3
mmol/l
11.1
11.6
0.39
298
1850
(3015377) Calcium [Moles/volume] in Serum or Plasma
923
7263
1.41
14.79
3.2
3.3
mmol/l
2.3
2.4
0.72
801
6157
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
108
476
2.32
14.50
1.4
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
108
476
2.32
14.50
1.4
1.3
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
140
689
2.08
14.32
6.0
6.1
mmol/l
1.3
1.3
0.34
127
600
(3019198) Lymphocytes [#/volume] in Blood
1193
9838
1.37
14.26
5.9
5.5
e9/l
1.9
1.9
0.02
1030
8504
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
1131
9247
1.38
14.26
4.7
4.2
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
1205
9953
1.37
14.26
6.0
5.7
e9/l
0.2
0.2
0.27
1042
8579
(3021601) Nitrite [Presence] in Urine by Test strip
1182
9737
1.37
14.20
6.4
5.2
estimate
0.0
0.0
0.00
179
1803
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
224
1301
1.78
13.95
1.7
1.5
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
38
94
4.08
13.94
1.2
1.1
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
568
4130
1.47
13.88
2.0
1.6
mg/l
1.6
1.5
0.17
435
3193
(3029937) Albumin [Presence] in Urine by Test strip
709
5377
1.43
13.84
5.8
4.2
estimate
0.0
0.0
1.08
172
1721
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
480
3379
1.51
13.76
3.3
3.0
e6/l
2.6
2.1
0.63
256
1894
(3037467) Urinalysis macro (dipstick) panel - Urine
1606
13945
1.36
13.53
5.5
4.5
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
36
88
4.12
13.43
1.7
2.1
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
31
68
4.59
13.25
1.7
1.3
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
31
68
4.59
13.25
1.1
1.1
ratio
1.1
1.0
—
5
25
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
1283
10787
1.35
13.18
5.4
5.9
umol/l
11.4
12.2
1.30
1208
10191
(3000850) Epithelial cells [#/volume] in Urine
624
4659
1.44
13.18
2.9
2.6
e6/l
4.8
5.2
0.44
551
4087
(3044889) 12 lead EKG panel
1603
13945
1.36
13.16
4.9
4.2
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
22
36
6.14
12.89
1.0
1.0
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
712
5472
1.40
12.71
1.7
1.6
nmol/l
19.2
19.9
0.51
635
4589
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
196
1129
1.79
12.55
7.8
8.7
mmol/l
24.3
24.4
0.15
174
1030
(40758558) Short blood count panel - Blood
640
4838
1.42
12.53
5.6
6.5
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
489
3521
1.47
12.43
2.8
2.4
umol/l
11.1
12.2
3.19
449
3210
(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay
26
52
5.03
12.37
1.0
1.0
%
94.5
98.4
0.26
26
39
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
33
81
4.10
12.26
1.0
1.0
u/l
1.2
1.3
0.09
14
44
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
144
758
1.95
12.24
3.4
2.5
u/ml
0.4
0.3
0.78
85
418
(3013650) Neutrophils [#/volume] in Blood by Automated count
1328
11308
1.34
12.15
8.3
8.6
e9/l
4.5
4.3
2.88
1158
9769
(3039000) Anion gap in Blood
103
484
2.17
11.91
6.2
7.0
mmol/l
11.3
11.2
0.16
92
431
(3018572) Chloride [Moles/volume] in Blood
103
484
2.17
11.91
6.2
7.0
mmol/l
105.5
105.3
0.18
92
431
(3044640) Blood type and Crossmatch panel - Blood
809
6415
1.37
11.78
2.9
2.5
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
174
986
1.81
11.77
4.6
3.5
mmol/l
23.9
24.1
0.16
149
874
(3051593) INR in Capillary blood by Coagulation assay
31
75
4.16
11.74
11.1
24.6
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
1648
14536
1.33
11.55
4.6
4.1
mm/h
14.5
14.1
0.39
1541
13222
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
169
955
1.82
11.54
4.8
5.1
%
1.7
1.6
0.38
156
898
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
1755
15647
1.34
11.28
7.6
7.3
u/l
82.3
80.8
0.37
1638
14577
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
254
1629
1.61
10.92
2.5
2.9
ml/min/173m2
60.2
60.5
0.05
110
714
(3052851) Hemolysis interference index of Serum or Plasma
120
623
1.96
10.65
3.6
3.4
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
163
940
1.78
10.42
5.0
5.1
%
0.9
0.9
0.23
150
881
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
320
2189
1.52
10.36
3.1
3.0
ng/l
243.6
256.7
0.20
296
1987
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
633
4912
1.37
10.34
2.9
2.4
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
1307
11294
1.30
9.97
3.2
3.1
u/l
53.3
55.3
0.25
1205
10224
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
24
55
4.38
9.76
1.1
1.1
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
421
5603
0.70
9.75
3.1
3.1
—
—
—
0
0
(3026782) Osmolality of Urine
569
4382
1.37
9.67
3.2
2.8
mosm/kgh2o
535.5
552.7
1.23
481
3719
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
1597
14222
1.29
9.41
4.1
3.9
pmol/l
15.1
15.1
0.23
1442
12611
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
888
7330
1.31
9.39
3.5
3.1
ng/l
1975.6
1871.3
0.23
782
6331
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
418
3071
1.42
9.35
2.9
2.5
%
19.7
22.0
3.03
334
2569
(3024891) Influenza virus A+B Ag [Presence] in Specimen
91
456
2.03
8.97
1.2
1.2
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
125
698
1.82
8.93
1.4
1.2
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
288
1988
1.50
8.91
2.4
2.6
g/l
65.8
66.1
0.29
263
1785
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
165
1004
1.68
8.74
1.3
1.3
au/ml
39.6
54.6
—
5
42
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
901
7518
1.29
8.62
5.6
4.2
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
964
8115
1.29
8.61
3.3
2.8
ug/l
129.8
150.1
2.30
883
7307
(3004789) Transferrin [Mass/volume] in Serum or Plasma
436
3273
1.39
8.58
2.8
2.4
g/l
2.2
2.3
0.46
402
2992
(3027945) Reticulocytes/100 erythrocytes in Blood
385
2831
1.42
8.54
2.0
2.4
%
1.8
1.8
0.29
334
2464
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
100
531
1.91
8.37
1.2
1.2
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
2077
19269
1.32
8.37
23.4
16.1
mg/l
27.2
27.2
0.01
1786
15597
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
71
334
2.15
8.29
1.5
1.4
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
100
535
1.90
8.19
1.2
1.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
100
537
1.89
8.11
1.2
1.2
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
87
446
1.98
8.08
3.4
2.6
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
255
1770
1.48
7.67
2.4
2.4
u/l
33.4
38.8
0.76
224
1493
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
23
63
3.66
7.43
2.5
2.7
umol/l
30.8
29.9
0.14
16
43
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
712
5869
1.28
7.25
3.1
3.0
u/l
31.8
34.6
0.77
666
5540
(42870588) Differential panel, method unspecified - Blood
802
6713
1.27
7.22
5.6
5.6
—
—
—
0
0
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
35
127
2.77
7.19
1.1
1.0
ng/l
264.6
320.3
0.97
23
79
(3034426) Prothrombin time (PT)
16
34
4.72
7.14
1.5
1.3
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
52
230
2.28
7.10
1.2
1.2
—
—
—
0
0
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
35
128
2.75
7.09
1.1
1.0
ng/l
705.0
679.7
0.12
24
76
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
35
128
2.75
7.09
1.1
1.0
ng/l
36.5
45.9
0.88
23
78
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
953
8162
1.25
7.01
2.5
2.2
nmol/l
76.1
79.3
2.91
849
7077
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
774
6474
1.27
6.96
2.6
2.4
u/l
54.2
58.8
2.93
714
5918
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
1880
17376
1.26
6.85
5.4
4.7
mu/l
1.9
2.1
1.70
1728
15453
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
37
145
2.57
6.58
1.1
1.1
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
292
2140
1.40
6.57
2.1
2.5
e9/l
70.1
67.9
0.51
217
1654
(40757494) Bilirubin.total [Moles/volume] in Blood
32
117
2.75
6.51
1.7
1.9
—
33.8
—
0
9
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
54
253
2.15
6.45
1.2
1.2
nmol/l
0.6
0.6
0.75
54
241
(3015171) Extractable nuclear Ab [Units/volume] in Serum
105
616
1.73
6.44
1.2
1.2
u/ml
0.3
0.9
0.82
17
50
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
11
18
6.12
6.41
8.8
17.5
mmol/l
5.0
5.6
0.51
11
18
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
238
1690
1.44
6.38
4.2
3.6
ng/l
105.5
95.4
0.83
213
1429
(3012516) Albumin [Mass/volume] in Urine
762
6419
1.26
6.35
3.3
3.3
mg/l
636.1
316.3
0.88
523
4096
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
183
2637
0.67
6.35
5.4
4.6
%
34.4
32.9
1.01
132
1646
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
48
221
2.19
6.01
1.2
1.2
nmol/l
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
53
254
2.10
6.00
1.2
1.2
nmol/l
0.3
0.3
—
6
12
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
22
68
3.25
5.97
1.2
1.1
ng/l
37.4
315.4
—
5
19
(3006504) Eosinophils/100 leukocytes in Blood
1035
9068
1.22
5.91
6.0
5.7
%
2.8
2.8
0.26
953
8344
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
173
1177
1.50
5.78
1.5
1.7
g/l
1.6
1.5
0.39
154
1005
(3019069) Monocytes/100 leukocytes in Blood
1038
9112
1.22
5.78
6.3
6.0
%
9.0
8.9
0.23
955
8416
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
149
985
1.54
5.70
2.2
1.8
ug/l
2.5
2.4
0.03
128
864
(3003327) Ova and parasites identified in Stool by Light microscopy
85
488
1.76
5.66
1.6
1.7
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
294
2213
1.36
5.63
1.3
1.3
titre
433.3
528.7
0.43
54
494
(3018010) Neutrophils/100 leukocytes in Blood
1038
9141
1.21
5.53
5.9
5.7
%
59.2
58.5
0.92
953
8433
(3009508) Creatinine [Moles/volume] in Urine
765
6533
1.23
5.51
3.2
3.2
mmol/l
7.0
7.2
0.55
649
5379
(3002385) Erythrocyte distribution width [Ratio]
1659
15293
1.21
5.44
27.9
19.7
%
14.1
13.9
4.04
1623
14907
(3017817) Protein [Mass] in Urine collected for unspecified duration
44
204
2.17
5.44
2.1
2.0
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
1003
8821
1.21
5.38
5.9
5.7
%
0.6
0.7
1.96
923
8129
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
200
1422
1.44
5.35
2.0
1.7
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
88
519
1.71
5.35
1.9
1.7
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
789
6785
1.23
5.28
3.8
4.0
mg/mmol
11.3
8.6
0.71
531
4302
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
1916
17938
1.22
5.27
7.3
6.3
mmol/mol
42.2
40.7
6.90
1800
16207
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
105
653
1.63
5.23
1.6
1.6
titre
140.0
210.8
—
6
37
(3006653) Thiamine [Moles/volume] in Blood
24
86
2.80
5.12
1.5
1.2
nmol/l
148.3
140.2
0.22
24
86
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
435
3526
1.27
4.90
1.3
1.2
u/ml
2.3
1.6
0.40
116
881
(3051611) Lipemic interference index of Serum or Plasma
44
215
2.06
4.80
4.1
3.4
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
1044
9291
1.20
4.79
6.1
5.9
%
25.3
26.2
1.99
960
8530
(3004716) Salmonella sp identified in Stool by Organism specific culture
115
748
1.56
4.78
1.3
1.3
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
29
120
2.43
4.69
1.1
1.1
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
12
29
4.14
4.61
1.5
1.2
—
—
—
0
0
(4198724)
12
29
4.14
4.61
1.4
1.4
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
18
59
3.06
4.49
1.6
1.1
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
369
2965
1.28
4.45
2.2
2.0
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
32
142
2.26
4.45
1.6
1.3
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
28
117
2.40
4.45
2.7
1.5
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
57
985
0.57
4.39
1.8
1.8
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
44
224
1.98
4.33
1.2
1.3
pmol/l
328.3
269.4
0.34
35
170
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
16
50
3.21
4.31
1.1
1.1
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
32
145
2.22
4.25
1.6
1.3
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
16
51
3.14
4.19
1.1
1.1
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
218
1644
1.35
4.16
2.1
2.1
nmol/l
375.0
378.4
0.09
184
1482
(46235355) HIV 1 and 2 tests - Meaningful Use set
257
1991
1.32
4.09
1.7
1.5
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
8
10
8.00
4.05
1.0
2.3
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
356
2887
1.26
3.98
1.3
1.2
iu/ml
28.9
38.3
0.74
93
889
(3004588) Protein electrophoresis panel - Serum or Plasma
221
1682
1.34
3.98
2.4
2.4
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
1786
16786
1.18
3.98
25.9
17.5
%
38.6
38.6
0.07
1107
10543
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
1065
9611
1.17
3.94
2.8
2.5
—
—
—
0
0
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
36
177
2.04
3.92
1.3
1.7
—
1466.7
—
0
6
(3024932) HLA-DR beta [Type]
13
38
3.42
3.88
1.1
1.1
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
2067
19689
1.20
3.88
21.6
15.6
—
—
—
0
0
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
36
178
2.03
3.87
1.8
1.4
u/ml
42.2
21.2
1.15
14
32
(3026493) Urate [Moles/volume] in Serum or Plasma
632
5463
1.20
3.85
3.0
2.8
umol/l
2959.0
7024.9
2.12
527
4623
(3019832) Treponema pallidum Ab [Presence] in Serum
106
713
1.50
3.85
1.4
1.5
—
—
—
0
0
(3022493) Free Hemoglobin [Mass/volume] in Plasma
19
71
2.68
3.80
5.7
1.8
mg/l
77.6
65.4
0.37
13
49
(3003181) Sodium [Moles/volume] in Urine
65
391
1.67
3.78
1.3
1.3
mmol/l
71.8
63.1
0.69
54
313
(3051651) Icteric interference index of Serum or Plasma
26
114
2.29
3.76
4.9
3.6
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
2120
20270
1.20
3.67
28.3
19.1
mmol/l
139.6
139.6
0.15
2078
19666
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
111
762
1.47
3.66
1.5
1.9
u/l
37.0
38.9
0.45
93
656
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
9
16
5.63
3.65
1.1
1.5
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
82
528
1.57
3.64
1.4
1.6
iu/ml
0.2
11.2
0.50
25
110
(3024471) HLA-A [Type]
13
40
3.25
3.61
1.0
1.0
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
39
204
1.92
3.60
1.9
1.6
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
12
35
3.43
3.60
1.2
1.1
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
138
991
1.41
3.59
2.8
3.2
pmol/l
4.1
4.4
3.98
121
853
(3023103) Potassium [Moles/volume] in Serum or Plasma
2122
20311
1.19
3.53
28.3
19.3
mmol/l
4.0
4.0
0.04
2071
19662
(3002256) Pathology report gross observation
210
2684
0.76
3.52
1.4
1.4
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
326
2657
1.25
3.50
3.4
3.8
u/l
229.8
248.2
3.26
306
2484
(40768800) Prostate Pathology biopsy report
29
569
0.50
3.47
1.2
1.2
—
—
—
0
0
(44806118)
41
222
1.86
3.43
1.2
1.5
—
—
—
0
0
(44790048)
41
222
1.86
3.43
1.2
1.5
—
—
—
0
0
(44790049)
41
222
1.86
3.43
1.2
1.5
—
—
—
0
0
(44790047)
41
222
1.86
3.43
1.2
1.5
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
14
48
2.92
3.28
1.1
1.1
—
—
—
0
0
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
18
71
2.54
3.28
1.5
1.6
%
97.5
94.6
0.12
18
66
(3020191) Ethanol [Moles/volume] in Serum or Plasma
25
115
2.18
3.26
1.1
1.4
promille
1.2
1.1
0.12
19
88
(3019225) pH of Specimen
180
2320
0.76
3.22
4.7
4.4
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
35
185
1.90
3.17
1.5
2.0
—
—
—
0
0
(4034850)
93
638
1.47
3.13
11.3
11.9
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
16
61
2.63
3.12
3.6
2.0
—
—
—
0
0
(4211845)
22
98
2.25
3.11
3.1
4.1
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
65
413
1.58
3.10
1.7
1.6
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
38
661
0.57
3.09
1.4
1.5
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
1854
17627
1.15
3.05
4.7
4.1
mmol/l
1.3
1.3
2.32
1702
15583
(3010144) Erythrocytes [#/volume] in Synovial fluid
37
202
1.84
3.05
1.5
1.3
e6/l
107008.4
75458.4
0.11
25
138
(4010399)
184
1426
1.31
2.98
1.5
1.4
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
40
226
1.78
2.96
1.5
1.9
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
11
35
3.14
2.92
3.0
4.1
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
13
46
2.83
2.90
1.1
1.1
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
13
46
2.83
2.90
1.1
1.1
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
922
8389
1.15
2.83
10.4
10.1
e9/l
0.0
0.0
0.98
737
6798
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
268
2195
1.24
2.79
2.2
2.5
umol/l
8.3
9.8
0.45
222
1919
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
18
78
2.31
2.73
1.1
1.0
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
34
188
1.81
2.72
2.1
1.6
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
561
4936
1.17
2.71
1.8
1.7
pmol/l
445.1
26288441.4
3.53
476
3979
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
19
85
2.24
2.69
1.2
1.1
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
130
976
1.35
2.66
1.3
1.3
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
41
243
1.69
2.61
1.5
1.8
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
194
1545
1.27
2.59
1.5
1.5
—
—
—
0
0
(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]
17
74
2.30
2.56
2.2
7.0
%
65.4
74.7
0.42
12
60
(3048689) Calprotectin [Mass/mass] in Stool
232
1892
1.24
2.53
1.9
2.1
ug/g
159.4
138.3
0.29
191
1466
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
18
81
2.23
2.52
1.1
1.2
—
—
—
0
0
(40768793) Breast Pathology biopsy report
20
392
0.51
2.48
1.4
1.3
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
9
26
3.46
2.47
1.0
1.0
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
42
255
1.65
2.47
1.6
1.6
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
57
373
1.54
2.46
1.1
1.1
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
11
39
2.82
2.46
1.3
1.1
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
39
233
1.68
2.43
1.7
1.5
%
54.8
62.6
0.56
26
151
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
56
369
1.52
2.36
1.4
1.3
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
40
243
1.65
2.36
1.5
1.7
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
14
58
2.42
2.35
1.4
1.5
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
40
244
1.65
2.32
1.5
1.8
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
367
3159
1.18
2.32
1.4
1.5
g/l
2.5
2.6
0.46
203
1851
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
54
355
1.53
2.30
1.3
1.5
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
172
1373
1.27
2.28
2.8
2.8
g/l
10.1
10.6
0.85
157
1240
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
107
801
1.35
2.27
2.8
2.7
—
—
—
0
0
(3027135) IgG subclass 1 [Mass/volume] in Serum
27
148
1.83
2.27
1.5
1.3
g/l
6.6
7.2
0.37
22
106
(3028192) IgG subclass 2 [Mass/volume] in Serum
27
148
1.83
2.27
1.5
1.3
g/l
3.4
2.8
0.93
22
105
(3024139) IgG subclass 3 [Mass/volume] in Serum
27
148
1.83
2.27
1.5
1.3
g/l
0.5
0.4
0.35
22
107
(44806071)
6
13
4.61
2.26
1.2
1.1
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
32
185
1.73
2.26
2.0
1.5
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
32
185
1.73
2.26
2.0
1.5
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
32
185
1.73
2.26
2.0
1.5
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
135
1718
0.77
2.26
4.8
4.0
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
40
246
1.63
2.26
1.5
1.8
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
40
246
1.63
2.26
2.4
1.9
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
12
47
2.55
2.26
1.2
1.1
miu/ml
1935.8
1518.4
0.59
12
47
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
7
18
3.89
2.24
1.0
1.2
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
21
106
1.98
2.24
1.7
2.6
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
19
93
2.05
2.20
1.1
1.2
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
73
516
1.42
2.19
1.7
1.6
e6/l
15845.4
16602.0
0.04
51
371
(3000570) Elastase.pancreatic [Mass/mass] in Stool
82
592
1.39
2.19
1.5
1.5
ug/g
265.6
281.9
0.31
58
357
(3027456) Digoxin [Moles/volume] in Serum or Plasma
85
618
1.38
2.18
3.5
3.1
nmol/l
0.8
0.8
0.27
69
473
(3021879) Hepatitis B virus core Ab [Presence] in Serum
127
984
1.30
2.14
1.3
1.3
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
33
196
1.69
2.14
1.4
1.7
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
51
338
1.52
2.12
1.5
1.4
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
38
235
1.62
2.12
1.5
1.4
g/l
0.7
0.8
0.05
33
175
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
121
934
1.31
2.10
2.5
2.4
g/l
7.3
7.5
0.37
85
685
(4062490)
27
152
1.78
2.10
1.4
1.3
—
—
—
0
0
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
21
109
1.93
2.09
1.1
1.1
nmol/l
3.7
7.6
—
5
20
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
8
25
3.20
2.09
1.0
1.0
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
58
398
1.46
2.05
1.3
1.2
—
—
—
0
0
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
19
96
1.98
2.04
2.3
1.7
nmol/l
15.3
17.4
0.85
19
88
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
120
932
1.30
2.01
2.5
2.4
g/l
3.5
3.8
1.85
82
655
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
78
568
1.38
2.00
2.3
2.3
ug/min
142.5
100.0
0.31
41
327
(36660697) Celiac disease serology panel - Serum
155
1244
1.26
2.00
1.2
1.2
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
10
38
2.63
2.00
1.4
1.1
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
120
933
1.30
1.99
2.5
2.4
—
—
—
0
0
(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay
9
32
2.81
1.99
1.2
3.2
%
156.9
191.4
—
9
27
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
15
70
2.14
1.97
1.2
1.3
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
26
148
1.76
1.97
3.9
2.1
e9/l
1.3
1.1
0.34
16
85
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
111
856
1.31
1.96
2.5
2.5
g/l
3.0
3.1
0.45
83
672
(3006462) Nitrate [Presence] in Urine
18
91
1.98
1.94
3.3
4.2
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
102
779
1.32
1.94
2.5
2.5
g/l
0.8
1.3
0.88
91
661
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
5
11
4.54
1.94
1.0
1.1
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
90
675
1.34
1.93
2.3
2.3
g/l
0.0
0.1
1.37
84
612
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
193
1594
1.22
1.93
1.8
1.7
%
1.5
1.5
0.54
174
1355
(3024869) Neuronal Ab [Presence] in Serum
9
33
2.73
1.92
1.0
1.1
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
18
92
1.96
1.88
1.0
1.0
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
44
291
1.52
1.88
18.0
7.1
mmol/l
8.4
7.4
1.12
35
237
(3013512) EKG study
588
6446
0.89
1.88
5.0
4.3
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
7
22
3.18
1.87
1.1
1.2
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
69
499
1.39
1.87
1.8
1.6
—
—
—
0
0
(3036603) Volume of Urine
20
107
1.87
1.85
2.0
1.7
ml
1765.3
1678.2
—
7
29
(3032352) Blasts [#/volume] in Cerebral spinal fluid
6
17
3.53
1.83
1.0
2.6
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
5
12
4.16
1.82
1.0
1.3
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
532
4799
1.13
1.79
1.3
1.3
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
204
1712
1.20
1.76
1.6
1.5
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
52
362
1.44
1.75
1.4
1.3
iu/l
26.5
31.5
0.58
44
309
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
46
313
1.47
1.74
1.2
1.2
u/ml
17.0
46.0
—
6
27
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
5
13
3.84
1.71
1.0
1.4
u/l
10.0
19.4
—
5
13
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
111
878
1.27
1.66
2.6
2.4
g/l
9.4
10.2
1.24
92
740
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
92
712
1.30
1.63
2.3
2.2
g/l
37.3
37.4
0.04
81
606
(3000034) Microalbumin [Mass/volume] in Urine
27
165
1.64
1.63
3.5
3.6
mg/l
64.7
30.8
0.29
17
127
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
20
112
1.79
1.63
4.1
2.1
e6/l
492.3
661.2
—
8
46
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
20
112
1.79
1.63
2.9
1.9
%
20.3
14.5
—
10
45
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
19
105
1.81
1.61
1.2
1.2
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
1960
18988
1.11
1.61
6.2
5.1
mmol/l
2.3
2.6
49.34
1834
16981
(3000494) Fungus identified in Specimen by Culture
258
2231
1.17
1.60
1.5
1.4
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
62
454
1.37
1.60
1.4
1.3
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
6
20
3.00
1.57
1.2
1.3
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
6
20
3.00
1.57
2.2
2.0
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
19
106
1.79
1.57
1.2
1.2
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
19
107
1.78
1.53
3.1
2.0
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
28
176
1.59
1.53
1.6
1.4
%
26.4
26.0
0.02
18
113
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
14
71
1.97
1.53
1.9
1.8
umol/l
54.8
96.0
—
8
49
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
142
1170
1.22
1.51
2.6
2.5
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
81
624
1.30
1.51
2.4
2.4
g/l
0.0
0.0
0.00
75
571
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
6
21
2.85
1.50
1.3
1.2
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
6
21
2.85
1.50
1.0
1.0
—
—
—
0
0
(1002224) Polysomnography panel
67
503
1.34
1.49
1.0
1.1
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
26
162
1.61
1.48
1.0
1.2
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
35
507
0.68
1.44
1.5
1.7
mg/l
3.6
4.1
0.14
30
376
(3026389) Candida sp identified in Specimen by Organism specific culture
36
244
1.48
1.43
1.7
1.3
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
312
2762
1.14
1.43
1.3
1.2
u/ml
12.5
12.9
0.03
107
991
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
96
763
1.26
1.42
1.1
1.0
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
1883
18251
1.10
1.42
5.2
4.5
mmol/l
1.4
1.4
16.02
1745
16286
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
41
286
1.44
1.41
1.5
1.3
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
68
517
1.32
1.41
1.2
1.4
—
9.5
—
0
11
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
81
631
1.29
1.41
2.4
2.4
g/l
0.0
0.0
0.00
75
572
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
7
29
2.41
1.39
1.0
1.1
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
14
74
1.89
1.38
1.9
1.2
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
12
60
2.00
1.37
1.2
1.1
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
74
572
1.30
1.37
1.5
1.4
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
60
450
1.34
1.37
2.5
1.7
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
38
535
0.70
1.35
3.4
3.5
mg/l
26.7
29.0
0.14
23
347
(3049717) Cytology report of Urine Cyto stain
120
985
1.23
1.35
3.1
2.7
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
46
332
1.39
1.33
2.6
2.5
mmol/l
105.3
105.7
0.28
46
327
(3041354) Potassium [Moles/volume] in Venous blood
46
332
1.39
1.33
2.6
2.5
mmol/l
4.1
4.1
0.16
46
327
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
19
113
1.68
1.30
1.3
1.5
%
61.2
68.6
0.30
13
86
(3001893) Eosinophils/100 leukocytes in Pleural fluid
17
98
1.74
1.30
1.2
1.5
%
2.1
2.1
0.00
11
79
(3033705) Calcium.ionized [Moles/volume] in Venous blood
45
326
1.38
1.28
2.6
2.5
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
68
525
1.30
1.28
1.7
1.6
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
10
48
2.08
1.27
1.2
1.1
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
304
2717
1.13
1.23
1.3
1.2
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
12
63
1.90
1.22
3.5
2.4
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
2082
20324
1.09
1.21
12.7
10.7
u/l
26.1
24.8
0.54
1999
19340
(3000492) Spirometry study
182
1572
1.17
1.20
1.5
1.5
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
19
117
1.62
1.17
1.5
1.5
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
35
248
1.41
1.15
1.4
1.3
u/ml
109.8
115.6
—
5
52
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
224
1973
1.14
1.14
2.1
2.0
g/l
0.2
0.2
0.06
201
1821
(3006184) Hemoglobin [Mass/volume] in Capillary blood
69
544
1.27
1.14
2.2
2.1
g/l
127.7
127.5
0.02
52
395
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
20
126
1.59
1.13
1.3
2.0
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
44
326
1.35
1.12
1.3
1.4
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
31
216
1.44
1.12
2.5
2.6
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
7
139
0.50
1.09
1.1
1.1
—
—
—
0
0
(3000012) Reticulocyte production index
7
139
0.50
1.09
1.0
1.5
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
29
201
1.44
1.08
1.2
1.3
mosm/kgh2o
281.2
275.6
0.77
21
144
(3017704) Immunofixation for Urine
23
152
1.51
1.08
1.8
1.6
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
19
120
1.58
1.07
1.1
1.4
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
19
120
1.58
1.07
1.1
1.4
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
139
1189
1.18
1.06
1.2
1.3
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
7
33
2.12
1.05
1.1
1.8
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
59
462
1.28
1.05
2.7
3.2
u/ml
4522.5
1186.3
0.38
53
422
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
12
203
0.59
1.04
1.7
1.5
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
441
4752
0.91
1.03
2.8
3.3
ug/l
0.8
0.8
0.22
302
3374
(3022621) pH of Urine by Test strip
165
1435
1.16
1.03
3.5
3.2
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
21
138
1.52
1.02
1.4
2.4
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
430
3965
1.10
1.01
4.8
4.5
—
—
—
0
0
(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood
10
53
1.89
1.00
3.3
2.1
%
32.3
26.3
—
10
46
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
161
1835
0.87
0.99
3.5
3.8
mmol/l
1.2
1.2
0.25
144
1572
(3047189) Immunofixation for 24 hour Urine
17
107
1.59
0.98
1.5
1.4
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
19
123
1.54
0.98
1.6
2.7
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
7
134
0.52
0.98
1.3
1.4
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
1891
18448
1.07
0.98
5.4
4.6
mmol/l
4.1
4.5
46.23
1768
16585
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
710
6696
1.08
0.98
4.5
4.7
%
23.3
22.0
1.21
332
3568
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
7
135
0.52
0.98
2.9
3.6
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
23
157
1.47
0.95
1.7
2.9
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
9
51
1.76
0.94
2.7
1.9
—
—
—
0
0
(4133840)
7
37
1.89
0.93
1.0
1.1
—
—
—
0
0
(43055442) Apixaban [Mass/volume] in Serum or Plasma
7
37
1.89
0.93
2.1
1.4
ug/l
163.9
104.8
—
7
32
(3028433) Virus identified in Specimen by Culture
11
62
1.77
0.93
1.3
1.2
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
17
109
1.56
0.92
2.1
1.8
—
—
—
0
0
(4035726)
155
1757
0.87
0.90
1.4
1.3
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
33
244
1.35
0.89
1.0
1.1
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
10
56
1.78
0.87
1.0
1.3
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
110
942
1.17
0.87
1.2
1.3
u/ml
173.2
212.6
0.44
92
866
(3004616) Nuclear Ab [Presence] in Serum
15
228
0.65
0.86
1.4
1.2
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
19
275
0.69
0.86
1.3
1.2
—
—
—
0
0
(21491868) Cryoglobulin [Mass/volume] in Serum
12
72
1.67
0.84
1.1
1.3
—
0.3
—
0
8
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
253
2296
1.11
0.84
3.8
3.7
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
69
568
1.22
0.84
1.4
1.5
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
14
88
1.59
0.83
1.2
1.2
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
1767
18009
0.94
0.83
21.0
15.4
ml/min/173m2
73.2
73.5
0.22
1484
14832
(3024731) MCV [Entitic volume]
2143
21046
1.07
0.83
33.6
23.7
fl
91.5
91.6
0.80
2110
20574
(3014271) Vancomycin [Susceptibility]
20
137
1.46
0.83
3.1
3.0
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
48
380
1.26
0.82
1.4
1.5
g/l
28.6
31.0
0.66
42
347
(3035941) MCH [Entitic mass]
2143
21048
1.07
0.82
33.5
23.6
pg
30.3
30.4
1.77
2110
20576
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
72
597
1.21
0.82
1.5
1.6
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
2143
21049
1.07
0.82
33.7
23.8
e12/l
4.4
4.4
3.64
2081
20248
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
60
489
1.23
0.81
1.7
1.5
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
2143
21053
1.07
0.80
33.7
23.8
e9/l
7.2
6.9
3.75
2082
20244
(3000963) Hemoglobin [Mass/volume] in Blood
2143
21053
1.07
0.80
33.9
23.9
g/l
130.9
133.0
8.25
2108
20587
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
8
47
1.70
0.80
11.9
6.8
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
2142
21045
1.07
0.80
33.6
23.8
e9/l
242.3
241.4
0.25
2089
20331
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
8
48
1.66
0.78
5.8
2.1
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
8
48
1.66
0.78
1.3
1.1
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
0
26
0.00
0.78
0.0
1.2
—
—
—
0
0
(40768441) Liver Pathology biopsy report
7
122
0.57
0.78
1.4
1.3
—
—
—
0
0
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
0
28
0.00
0.76
0.0
1.9
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
261
2388
1.10
0.76
3.4
4.0
ug/l
7.3
23.5
2.22
220
1980
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
76
893
0.84
0.74
2.0
1.8
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
5
24
2.08
0.74
2.8
2.3
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
5
24
2.08
0.74
2.8
2.2
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
8
136
0.59
0.72
1.0
1.0
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
5
25
2.00
0.72
1.2
1.2
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
5
25
2.00
0.72
1.0
1.1
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
14
92
1.52
0.71
4.1
6.6
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
10
60
1.67
0.71
1.0
1.2
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
17
117
1.45
0.71
3.8
2.8
%
36.0
39.5
—
6
41
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
7
41
1.71
0.69
1.1
1.2
%
110.4
101.7
—
7
36
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
15
101
1.48
0.69
1.0
1.5
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
22
296
0.74
0.69
1.2
1.8
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
5
27
1.85
0.68
1.2
1.0
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
10
61
1.64
0.68
2.8
1.8
—
—
—
0
0
(3012565) Volume of 24 hour Urine
5
93
0.54
0.66
1.8
2.3
ml
1942.0
1872.2
—
5
80
(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma
7
43
1.63
0.66
1.0
1.1
—
6.4
—
0
7
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
7
44
1.59
0.65
1.0
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
7
44
1.59
0.65
1.0
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
7
44
1.59
0.65
1.0
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
7
44
1.59
0.65
1.0
1.1
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
76
880
0.86
0.65
1.4
1.4
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
35
277
1.26
0.64
1.6
1.6
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
45
369
1.22
0.61
1.1
1.2
—
—
—
0
0
(3036782) Glucose [Moles/volume] in Pleural fluid
32
252
1.27
0.61
1.3
1.4
mmol/l
6.4
6.4
0.04
32
235
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
1912
18778
1.05
0.61
5.4
4.9
mmol/l
6.2
6.1
4.18
1734
16632
(3038026) Centromere Ab [Units/volume] in Serum
11
163
0.67
0.60
1.2
1.1
—
89.1
—
0
5
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
20
0.00
0.60
0.0
1.1
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
10
151
0.66
0.60
1.6
1.5
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
36
289
1.25
0.60
1.3
1.5
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
49
407
1.20
0.60
1.6
1.8
iu/l
2.3
4.9
3.32
14
137
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
22
0.00
0.59
0.0
1.0
—
26.2
—
0
22
(3005570) Glucose [Moles/volume] in Urine
30
236
1.27
0.59
1.6
2.0
—
—
—
0
0
(21494434) Karyotype in Bone marrow
16
219
0.73
0.58
1.4
1.2
—
—
—
0
0
(3024263) Appearance of Synovial fluid
16
114
1.40
0.58
1.6
1.6
—
—
—
0
0
(3023383) Lactate [Moles/volume] in Pleural fluid
13
89
1.46
0.57
1.3
1.4
mmol/l
3.5
3.4
0.06
13
83
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
38
309
1.23
0.57
1.4
1.6
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
517
4920
1.06
0.57
1.7
1.6
mmol/l
1.3
1.3
0.14
454
4031
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
8
54
1.48
0.57
1.0
1.2
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
30
374
0.80
0.56
1.5
1.3
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
49
410
1.20
0.56
1.3
1.5
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
69
792
0.87
0.55
2.0
3.1
g/l
0.3
0.3
0.13
30
309
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
41
338
1.21
0.55
6.8
5.0
iu/ml
569.3
5146.2
—
10
47
(3004809) Band form neutrophils/100 leukocytes in Blood
31
383
0.81
0.55
3.4
3.9
%
0.9
1.6
0.96
26
283
(3028308) Erythrocytes [#/volume] in Pleural fluid
37
302
1.23
0.54
1.4
1.4
e6/l
120212.0
73575.6
0.20
19
176
(3012501) Base excess in Blood by calculation
43
512
0.84
0.53
5.1
5.0
mmol/l
3.0
2.8
0.22
32
351
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
11
158
0.69
0.53
1.2
1.1
—
64.3
—
0
12
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
31
381
0.81
0.53
2.5
3.6
%
58.5
58.8
0.04
31
381
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
92
815
1.13
0.53
2.4
3.1
u/ml
6281.5
2224.0
0.37
75
693
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
45
377
1.19
0.52
2.0
1.6
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
16
117
1.37
0.51
1.3
1.2
mmol/l
12.3
11.4
—
5
36
(3038071) Oxygen [Partial pressure] in Mixed venous blood
6
40
1.50
0.51
14.3
7.1
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
54
461
1.17
0.51
3.4
2.7
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
13
92
1.41
0.50
1.1
1.1
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
10
67
1.49
0.49
1.2
1.2
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
7
45
1.55
0.48
1.0
2.7
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
7
45
1.55
0.48
2.0
1.4
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
136
1240
1.10
0.48
3.1
2.7
e6/l
0.2
0.3
0.48
136
1208
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
92
821
1.12
0.48
3.3
3.4
mg/l
30.3
74.6
1.87
80
673
(3034860) Kappa light chains.free [Mass/volume] in Serum
92
821
1.12
0.48
3.3
3.4
mg/l
104.7
134.0
0.14
79
670
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
15
110
1.36
0.48
1.3
1.1
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
14
102
1.37
0.46
1.4
1.3
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
14
102
1.37
0.46
1.4
1.3
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
15
111
1.35
0.46
1.3
1.1
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
89
796
1.12
0.46
3.3
3.4
ratio
1.2
1.9
—
5
57
(3037556) Urate [Mass/volume] in Serum or Plasma
5
81
0.62
0.45
3.6
1.4
—
—
—
0
0
(44806420)
5
83
0.60
0.45
2.0
2.4
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
8
119
0.67
0.45
1.4
1.5
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
20
253
0.79
0.45
1.0
1.1
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
69
608
1.14
0.45
1.7
1.7
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
32
264
1.21
0.45
1.3
1.3
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
7
50
1.40
0.45
2.6
1.2
—
—
—
0
0
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
16
121
1.32
0.43
3.3
2.2
ug/min
31.5
132.5
—
8
27
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
20
157
1.27
0.42
1.3
1.2
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
5
32
1.56
0.42
1.0
1.1
—
—
—
0
0
(3025577) Chromium [Mass/volume] in Blood
11
150
0.73
0.42
1.9
2.0
ug/l
2.0
1.9
0.05
11
125
(3012441) Differential panel - Pleural fluid
34
285
1.19
0.41
1.4
1.5
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
31
369
0.84
0.41
2.4
3.3
e9/l
4.2
4.4
0.34
31
369
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
26
212
1.23
0.41
1.1
1.1
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
(3013727) Leukocytes other/100 leukocytes in Blood
10
70
1.43
0.41
1.7
4.2
%
59.0
55.9
—
10
65
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
14
183
0.76
0.41
1.5
1.3
—
—
—
0
0
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
0
17
0.00
0.40
0.0
1.0
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
27
222
1.22
0.40
1.1
1.0
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
15
114
1.31
0.40
2.5
2.3
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
225
2116
1.07
0.40
1.6
1.4
—
—
—
0
0
(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method
0
18
0.00
0.40
0.0
1.0
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
16
123
1.30
0.40
1.6
1.6
u/field
4.8
2.2
—
5
90
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
5
35
1.43
0.39
1.0
1.1
—
—
—
0
0
(3014891) Appearance of Pleural fluid
5
35
1.43
0.39
1.0
1.5
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
5
35
1.43
0.39
1.8
1.5
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
24
290
0.82
0.38
1.3
1.2
miu/ml
258.3
219.8
—
9
119
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
89
975
0.91
0.38
2.4
1.9
—
—
—
0
0
(3022313) Gas panel - Capillary blood
96
1047
0.91
0.37
4.0
3.7
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
12
89
1.35
0.37
1.1
1.1
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
34
289
1.18
0.37
3.2
2.5
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
8
114
0.70
0.37
1.5
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
8
114
0.70
0.37
1.5
1.4
—
—
—
0
0
(3027923) C peptide [Moles/volume] in Serum or Plasma
13
98
1.33
0.37
1.2
1.3
nmol/l
1.2
1.1
—
8
77
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
8
115
0.69
0.37
1.5
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
8
115
0.69
0.37
1.5
1.4
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
39
336
1.16
0.36
1.4
1.4
e6/l
801.8
1723.2
2.52
25
242
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
9
125
0.72
0.35
1.7
1.5
—
—
—
0
0
(3035880) pH of Pleural fluid
20
162
1.23
0.35
1.3
1.3
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
9
126
0.71
0.35
1.7
1.5
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
19
153
1.24
0.34
1.8
1.6
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
6
45
1.33
0.33
1.8
1.7
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
112
1205
0.92
0.33
4.4
3.7
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
32
274
1.17
0.33
1.7
1.7
—
—
—
0
0
(4094501)
54
481
1.12
0.33
1.1
1.1
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
26
306
0.85
0.33
1.1
1.1
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
6
89
0.67
0.33
1.5
1.5
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
23
191
1.20
0.32
1.1
1.1
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
46
517
0.89
0.32
3.4
2.5
%
15.8
15.8
0.00
31
262
(3034770) Mitochondria Ab [Titer] in Serum
40
453
0.88
0.31
1.3
1.1
—
1206.0
—
0
15
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
16
197
0.81
0.31
1.6
1.6
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
14
110
1.27
0.31
1.4
1.1
—
—
—
0
0
(3008898) HLA-B27 [Presence]
47
417
1.13
0.31
1.0
1.1
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
7
52
1.34
0.31
1.3
1.0
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
21
250
0.84
0.30
1.7
1.6
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
14
111
1.26
0.29
1.4
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
14
111
1.26
0.29
1.4
1.1
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
83
897
0.92
0.29
1.2
1.3
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
14
173
0.81
0.29
1.0
1.1
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
67
611
1.10
0.28
3.5
3.0
mmol/l
24.8
25.2
0.26
59
525
(3047007) Chlamydophila sp Ab [Presence] in Serum
24
204
1.18
0.28
1.3
1.2
—
—
—
0
0
(1616796) Gas panel - Central venous blood
47
521
0.90
0.27
4.0
3.9
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
12
94
1.27
0.27
1.6
1.4
g/l
0.8
1.0
1.52
12
94
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
26
223
1.16
0.27
1.7
2.2
u/field
3.2
1.9
—
5
80
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
82
883
0.92
0.27
4.3
4.0
mmol/l
24.6
24.9
0.41
73
804
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
35
308
1.14
0.27
1.2
1.5
—
—
—
0
0
(3008037) Lactate [Moles/volume] in Venous blood
63
575
1.10
0.27
4.1
3.3
mmol/l
1.6
1.6
0.38
63
560
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
29
252
1.15
0.26
1.1
1.2
u/ml
298.7
289.6
0.06
16
140
(3003740) Influenza virus B Ag [Presence] in Specimen
14
171
0.82
0.26
1.0
1.1
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
23
196
1.17
0.26
1.0
1.1
u/l
49.6
57.9
0.77
14
137
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
5
75
0.66
0.25
1.0
1.3
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
5
75
0.66
0.25
2.2
1.6
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
17
141
1.20
0.25
3.5
4.9
u/ml
282.7
37.3
—
6
40
(3016650) Hepatitis A virus Ab [Presence] in Serum
21
244
0.86
0.24
1.1
1.1
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
507
5184
0.97
0.24
4.3
3.6
—
—
—
0
0
(3022145) Colonoscopy Study observation
220
2108
1.04
0.24
1.2
1.3
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
182
1737
1.05
0.23
1.6
1.6
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
7
91
0.77
0.22
1.4
1.4
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
35
313
1.12
0.22
1.2
1.3
u/l
10.5
10.3
0.03
28
251
(3047352) Trisomy 18 risk [Likelihood] in Fetus
7
92
0.76
0.22
1.4
1.4
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
7
94
0.74
0.22
1.4
1.5
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
11
88
1.25
0.22
1.1
1.1
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
48
523
0.91
0.22
1.5
1.7
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
39
352
1.11
0.21
1.7
1.7
—
—
—
0
0
(4024509)
25
219
1.14
0.21
1.4
1.6
—
—
—
0
0
(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
5
42
1.19
0.21
3.6
1.3
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
21
182
1.15
0.21
2.4
2.3
ml
693.3
630.7
0.38
15
112
(3010421) pH of Blood
56
603
0.92
0.20
4.5
4.7
ph
7.4
7.4
0.10
42
503
(3028271) Lactate [Moles/volume] in Capillary blood
36
395
0.91
0.19
2.5
1.9
mmol/l
1.7
1.7
0.07
36
383
(3017732) Neutrophils [#/volume] in Blood
134
1278
1.05
0.19
3.6
3.3
e9/l
4.0
4.2
0.17
100
915
(3032773) Endomysium IgG Ab [Titer] in Serum
15
127
1.18
0.19
1.0
1.1
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
33
298
1.11
0.19
1.2
1.1
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
10
81
1.23
0.18
4.2
1.7
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
10
81
1.23
0.18
4.2
1.7
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
88
831
1.06
0.18
2.2
1.7
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
40
366
1.09
0.18
1.8
1.6
—
—
—
0
0
(3038515) Glucose [Moles/volume] in Venous blood
59
550
1.07
0.18
4.2
3.4
mmol/l
7.9
7.7
0.18
59
536
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
48
444
1.08
0.17
1.3
1.2
u/ml
7.0
7.1
0.01
11
69
(3033799) Differential panel - Peritoneal fluid
7
62
1.13
0.17
1.6
1.9
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
7
62
1.13
0.17
2.1
1.5
—
—
—
0
0
(4015189)
5
66
0.76
0.17
1.2
2.4
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
20
176
1.13
0.17
1.3
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
13
110
1.18
0.16
1.4
1.1
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
8
68
1.17
0.16
1.6
1.4
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
30
272
1.10
0.16
1.1
1.2
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
780
7886
0.98
0.16
2.2
2.2
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
10
83
1.20
0.15
4.2
1.7
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
65
613
1.06
0.15
1.4
1.5
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
93
887
1.05
0.14
2.1
2.0
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
14
121
1.16
0.14
1.1
1.2
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
9
83
1.08
0.14
1.9
1.9
ug/l
42.3
52.5
—
9
78
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
33
356
0.92
0.14
4.0
3.1
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
31
285
1.09
0.13
1.5
1.5
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
23
208
1.10
0.13
1.7
1.9
u/l
6997.3
3273.5
—
5
75
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
27
247
1.09
0.13
4.9
3.7
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
45
477
0.94
0.12
1.2
1.2
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
14
158
0.88
0.12
1.2
1.1
u/ml
0.4
1.6
—
8
63
(3038177) Helicobacter pylori Ab [Presence] in Serum
20
220
0.91
0.12
1.5
1.3
—
—
—
0
0
(40768443) Skin Pathology biopsy report
94
903
1.04
0.12
1.2
1.2
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
23
250
0.92
0.11
6.0
4.4
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
142
1377
1.03
0.11
4.0
3.6
mmol/l
1.6
2.0
0.49
98
1011
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
150
1457
1.03
0.11
3.9
3.6
kpa
5.2
5.2
0.01
135
1328
(3045424) Erythrocytes [Presence] in Urine
34
318
1.07
0.10
1.8
1.4
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
156
1518
1.03
0.10
3.9
4.1
%
3.0
0.4
0.42
29
402
(3042631) Mycobacterium sp identified in Specimen
32
340
0.94
0.10
1.8
2.8
—
—
—
0
0
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
5
44
1.13
0.10
1.6
1.2
g/l
0.3
0.3
—
5
34
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
828
8329
0.99
0.10
4.7
5.5
ug/l
2.8
4.4
1.60
739
7346
(3036071) Salmonella sp Ab [Titer] in Serum
5
45
1.11
0.09
1.0
1.0
—
—
—
0
0
(44813793)
12
106
1.13
0.09
1.0
1.0
—
—
—
0
0
(3011648) Oxygen content in Venous blood
18
164
1.10
0.09
1.2
1.9
%
11.4
10.3
0.35
18
164
(3026250) Tacrolimus [Mass/volume] in Blood
5
48
1.04
0.09
36.0
32.3
ug/l
7.3
6.8
—
5
41
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
13
116
1.12
0.09
1.8
3.2
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
6
54
1.11
0.09
2.7
1.6
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
6
55
1.09
0.08
1.8
1.5
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
71
684
1.04
0.08
5.1
4.6
—
—
—
0
0
(3009343) pH of Capillary blood
147
1435
1.02
0.08
3.9
3.6
ph
7.4
7.4
0.14
19
178
(40761539) Cells [Type] in Urine sediment by Light microscopy
5
60
0.83
0.08
1.0
1.2
—
—
—
0
0
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
5
60
0.83
0.08
2.0
2.2
ug/l
19.2
148.3
—
5
54
(3043410) Blood group antigens tested for on Red Blood Cells
5
62
0.80
0.08
10.6
1.4
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
159
1556
1.02
0.07
3.9
3.9
%
0.5
0.6
0.15
28
374
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
94
963
0.97
0.07
1.2
1.2
iu/ml
92.4
140.5
0.68
29
335
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
14
127
1.10
0.07
2.1
2.3
—
—
—
0
0
(4146454)
24
255
0.94
0.07
2.5
2.7
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
8
76
1.05
0.07
3.1
2.1
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
8
76
1.05
0.07
3.1
2.1
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
28
265
1.05
0.06
1.8
1.3
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
9
105
0.85
0.06
1.1
1.3
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
15
162
0.92
0.06
1.2
1.0
u/ml
1.6
5.8
—
8
76
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
12
131
0.91
0.06
1.3
1.5
nmol/l
0.2
0.3
—
7
101
(3014051) Protein [Presence] in Urine by Test strip
46
475
0.97
0.05
2.3
2.2
—
—
—
0
0
(3004451) EKG impression Narrative
13
119
1.09
0.05
1.1
1.3
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
10
90
1.11
0.05
1.1
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
10
90
1.11
0.05
1.1
1.0
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
11
120
0.91
0.05
1.4
1.1
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
33
316
1.04
0.05
1.1
1.2
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
137
1350
1.01
0.03
2.6
2.1
nmol/l
11.7
12.0
0.13
118
1160
(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
18
170
1.06
0.03
2.5
1.8
mg/l
3.6
4.8
1.20
18
163
(3045788) Cell count panel - Pleural fluid
27
259
1.04
0.03
1.6
1.4
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
13
121
1.07
0.03
1.2
1.5
u/l
19.8
6.5
—
5
62
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
76
745
1.02
0.03
1.9
1.7
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
25
258
0.97
0.02
1.1
1.1
iu/ml
15.6
84.0
—
7
53
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
27
261
1.03
0.02
1.8
1.3
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
18
187
0.96
0.02
1.2
1.1
u/ml
0.2
1.8
—
6
73
(3035320) C reactive protein [Mass/volume] in Body fluid
15
143
1.05
0.01
4.4
2.3
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
23
236
0.97
0.01
1.3
1.3
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
174
1728
1.00
0.01
4.2
4.0
%
1.2
0.9
0.46
39
528
(3028026) IgM [Mass/volume] in Serum or Plasma
110
1091
1.01
0.00
2.0
1.9
g/l
1.1
1.6
2.84
104
973
(3006922) Hepatitis E virus Ab [Presence] in Serum
10
94
1.06
0.00
1.3
1.0
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
13
132
0.98
0.00
1.3
1.2
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
17
174
0.97
0.00
1.1
1.2
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
26
261
0.99
0.00
1.8
1.3
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
10
96
1.04
0.00
1.0
1.1
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
64
637
1.00
0.00
3.9
3.5
—
—
—
0
0
(4281824)
19
190
1.00
0.00
1.2
1.1
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
20
196
1.02
0.00
1.5
1.2
mmol/l
6.9
7.8
0.75
15
134
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
16
158
1.01
0.00
1.1
1.2
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
19
192
0.99
0.00
1.1
1.1
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
26
262
0.99
0.00
1.8
1.3
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
11
112
0.98
0.00
3.9
1.5
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
11
112
0.98
0.00
3.9
1.5
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
11
112
0.98
0.00
3.9
1.5
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
11
112
0.98
0.00
3.9
1.5
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
27
264
1.02
0.00
1.8
1.3
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
164
1637
1.00
0.00
4.4
4.1
%
0.4
0.1
0.85
35
484
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
194
1939
1.00
0.00
1.4
1.3
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
27
271
0.99
0.00
2.0
2.1
u/ml
7449.3
1181.4
0.39
27
262
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
18
180
1.00
0.00
1.1
1.0
u/ml
1.7
1.8
—
8
56
(3014133) Dog dander IgE Ab [Units/volume] in Serum
11
114
0.96
0.00
1.0
1.0
u/ml
0.1
2.4
—
6
46
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
26
260
1.00
0.00
1.8
1.3
—
—
—
0
0
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3001556) Androgen free Index in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3038864) risperiDONE [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
9.2
—
0
6
(3010937) Rubella virus Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3027974) Hepatitis B virus e Ag [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3040661) Urea [Moles/volume] in Peritoneal dialysis fluid
0
6
0.00
0.00
0.0
5.0
—
16.7
—
0
6
(3033093) Yersinia sp IgM Ab [Titer] in Serum
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma
0
6
0.00
0.00
0.0
1.5
—
2.7
—
0
6
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid
0
6
0.00
0.00
0.0
5.0
—
398.7
—
0
6
(3011325) HIV 1+2 Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025443) Phadiatop IgE Ab [Units/volume] in Serum
6
68
0.88
0.00
1.0
1.0
—
10.3
—
0
10
(3051101) Glucose [Moles/volume] in Cord blood
5
50
1.00
0.00
5.6
6.3
—
—
—
0
0
(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
7
69
1.01
0.00
1.0
1.0
—
—
—
0
0
(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
0
8
0.00
0.00
0.0
1.9
—
—
—
0
0
(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3041184) Isoniazid [Presence] in Urine
0
7
0.00
0.00
0.0
1.9
—
—
—
0
0
(3045519) Venlafaxine [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
152.6
—
0
5
(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method
0
9
0.00
0.00
0.0
7.9
—
—
—
0
0
(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022411) Androstenedione [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.6
—
2.6
—
0
9
(3041678) Intrinsic coagulation system thromboelastography panel - Blood
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay
0
9
0.00
0.00
0.0
1.9
—
25.9
—
0
9
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
5
55
0.91
0.00
2.8
2.8
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40763480) Human metapneumovirus Ag [Presence] in Specimen
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
5
52
0.96
0.00
1.0
1.3
—
—
—
0
0
(3013762) Body weight Measured
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3049242) von Willebrand panel - Platelet poor plasma
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
5
53
0.94
0.00
3.2
1.2
ug/l
9.7
8.7
—
5
53
(3038205) Alternaria alternata IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012989) Citrate [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.6
—
2.2
—
0
5
(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose
0
5
0.00
0.00
0.0
1.0
—
7.7
—
0
5
(40758358) Immune stain study
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017937) Magnesium [Moles/time] in 24 hour Urine
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint I9_CEREBDOTH and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| I9_CEREBDOTH | 1.804 [1.65, 1.98] | < 0.001 |
| Birth year | 0.993 [0.99, 1.0] | 0.089 |
During the follow-up period (1.1.1998 — 31.12.2019), 4689 out of 9333 females with I9_CEREBDOTH died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| I9_CEREBDOTH | 1.745 [1.58, 1.93] | < 0.001 |
| Birth year | 0.983 [0.97, 0.99] | < 0.001 |
During the follow-up period (1.1.1998 — 31.12.2019), 4617 out of 9686 males with I9_CEREBDOTH died.
Mortality risk
Mortality risk for people of age
years, who have I9_CEREBDOTH.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.154% | 0.319% |
| 5 | 0.957% | 1.904% |
| 10 | 2.44% | 4.433% |
| 15 | 4.835% | 8.401% |
| 20 | 8.489% | 14.215% |
Relationships between endpoints
↥Index endpoint: I9_CEREBDOTH – Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data